Oral tolerance physiologic basis and clinical applications

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 487-537

  Mowat, Allan McI ^a,b   Faria, Ana M C ^c   Weiner, Howard L ^d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882878432     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50031-0     Document Type: Chapter

References (643)

1. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2:725-731.
2. Akbari O., Freeman G.J., Meyer E.H., Greenfield E.A., Chang T.T., Sharpe A.H., Berry G., DeKruyff R.H., Umetsu D.T. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002, 8:1024-1032.
3. Alpan O., Rudomen G., Matzinger P. The role of dendritic cells, B cells and M cells in gut-oriented immune responses. J. Immunol. 2001, 166:4843-4852.
4. Al-Sabbagh A., Miller A., Santos L.M.B., Weiner H.L. Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 1994, 24:2104-2109.
5. Al-Sabbagh A., Nelson P., Sobel R.A., Weiner H.L. Antigen-driven peripheral immune tolerance: Suppression of experimental autoimmune encephalomyelitis and collagen induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell. Immunol. 1996, 171:111-119.
6. Al-Sabbagh A.M., Goad M.E.P., Weiner H.L., Nelson P.A. Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis. J. Neurol. Res. 1996, 45:424-429.
7. Al-Sabbagh A., Garcia G., Slavin A., Weiner H.L., Nelson P. Neurology 1997, 48:A421.
8. Andrade M.C., Vaz N.M., Faria A.M.C. Ethanol-induced colitis prevents oral tolerance induction in mice. Braz. J. Med. Biol. Res. 2003, 36:1227-1232.
9. Andre C., Heremans J.F., Vaerman J., Cambiasco C.L. A mechanism for the induction of immunological tolerance by antigen feeding: Antigen-antibody complexes. J. Exp. Med. 1975, 142:1509-1519.
10. Arakawa T., Yu J., Chong D.K., Hough J., Engen P.C., Langridge W.H. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 1998, 16:934-938.
11. Aramaki Y., Fujii Y., Suda H., Suzuki I., Yadomae T., Tsuchiya.S. Induction of oral tolerance after feeding of ragweed pollen extract in mice. Immunol. Lett. 1994, 40:21-25.
12. Aroeira L.S., Cardillo F., De-Albuquerque D., Vaz N.M., Mengel J. Anti-IL-10 treatment does not block either the induction or the maintenance of orally induced tolerance to OVA. Scand. J. Immunol. 1995, 44:319-323.
13. Artik S., Haarhuis K., Wu X., Begerow J., Gleichmann E. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J. Immunol. 2001, 15:167.
14. Artik S., Haarhuis K., Wu X., Begerow J., Gleichmann E. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J. Immunol. 2001, 15:6794-6803.
15. kip1 degradation. J. Immunol. 2002, 169:4723-4731.
16. Asherson G.L., Zembala M., Perera M.A.C.C., Mayhew B., Thomas W.R. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's Patches, mesenteric lymph nodes and other lymphoid tissues. Cell. Immunol. 1977, 33:145-155.
17. Asherson G.L., Perera M.A.C.C., Thomas W.R. Contact sensitivity and the DNA response in mice to high and low doses of oxazolone: Low dose unresponsiveness following painting and feeding and its prevention by pretreatment with cyclophosphamide. Immunology 1979, 36:449-459.
18. Astori M., von Garnier C., Kettner A., Dufour N., Corradin G., Spertini F. Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. J. Immunol. 2000, 165:3497-3505.
19. Bach J.F., Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 2001, 19:131-161.
20. Bach J.F., Francois Bach J. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003, 3:189-198.
21. Bagot M., Charue D., Flechet M.L., Terki N., Toma A., Revuz J. Oral desensitization in nickel allergy induces a decrease in nickel-specific T-cells. Eur. J. Dermatol. 1995, 5:614-617.
22. Banchereau J., Steinman R.L. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
23. Barchan D., Souroujon M.C., Im S.H., Antozzi C., Fuchs S. Antigen-specific modulation of experimental myasthenia gravis: Nasal tolerization with recombinant fragments of the human acetylcholine receptor α-subunit. Proc. Natl. Acad. Sci. USA 1999, 96:8086-8091.
24. Bardos T., Czipri M., Vermes C., Zhang J., Mikecz K., Glant T.T. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice. Clin. Exp. Immunol. 2002, 129:224-231.
25. Barnard J.A., Warwick G.J., Gold L.I. Localization of transforming growth factor β isoforms in the normal murine small intestine and colon. Gastroenterology 1993, 105:67-73.
26. Barnett M.L., Combitchi D., Trentham D.E. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arth. Rheumat. 1996, 39:623-628.
27. Barnett M.L., Kremer J.M., St Clair E.W., Clegg D.O., Furst D., Weisman M., Fletcher M.J., Chasan-Taber S., Finger E., Morales A., Le C.H., Trentham D.E. Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial. Arth. Rheumat. 1998, 41:290-297.
28. + cells on the induction and maintenance of oral tolerance. Cell. Immunol. 1995, 163:19-29.
29. Barone K.S., Tolarova D.D., Ormsby I., Doetschman T., Michael J.G. Induction of oral tolerance in TGF-β1 null mie. J. Immunol. 1998, 161:154-160.
30. Barone K.S., Herms B., Karlosky L., Murray S., Qualls J. Effect of in vivo administration of anti-CTLA-4 mAb and IL-12 on the induction of low dose oral tolerance. Clin. Exp. Immunol. 2002, 130:196-203.
31. Barratt M.E.J., Powell J.R., Allen W.D., Porter P. Immunopathology of intestinal disorders in farm animals. Immunopathology of the Small Intestine 1987, 253-258. John Wiley and Sons, Chichester, UK. M.N. Marsh (Ed.).
32. Becker K.J., McCarron R.M., Hallenbeck J.M. Oral tolerance to myelin basic protein decreases stroke size. Stroke 1997, 28:246.
33. Bellussi L., Bologna M., Di Stanislao C., Lauriello M., Mezzedimi C., Muzi P., Passali G.C., Passali D. Simplified local nasal immunotherapy in mite dust allergic rhinitis. J. Investig. Allergol. Clin. Immunol. 2002, 12:42-47.
34. Benson J.M., Stuckman S.S., Cox K.L., Wardrop R.M., Gienapp I.E., Cross A.H., Trotter J.L., Whitacre C.C. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J. Immunol. 1999, 162:6247-6254.
35. + T cells that suppress adoptive transfer of diabetes. J. Autoimmun. 1994, 7:655-663.
36. Bergerot I., Fioix C., Peterson J., Moulin V., Rask C., Fabien N., Lindblad M., Mayer A., Czerkinsky C., Holmgren J., Thivolet C. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1997, 94:4610-4614.
37. Bertoni M., Cosmi F., Bianchi I., Di Bernardino L. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy: Results of preseasonal treatment in grass pollen rhinitis. Ann. Allergy Asthma Immunol. 1999, 82:47-51.
38. Besredka A. De L'Anaphylaxie: Sixieme memoire de l'anaphylaxie lactique. Ann. Instit. Pasteur 1909, 23:166-176.
39. Beyer K., Castro R., Birnbaum A., Benkov K., Pittman N., Sampson H.A. Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin. Immunol. 2002, 109:707-713.
40. Bhan A.K., Mizoguchi E., Smith R.N., Mizoguchi A. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol. Rev. 1999, 169:195-207.
41. Bhogal B.S., Karkhanis Y.D., Bell M.K., Sanchez P., Zemcik B., Siskind G.W., Thorbecke G.J. Production of auto-anti-idiotypic antibody during the normal immune response. XII. Enhanced auto-anti-idiotypic antibody production as a mechanism for apparent B cell tolerance in rabbits after feeding antigens. Cell Immunol. 1986, 101:93-104.
42. + DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003, 108:481-492.
43. Bitar D., Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol. 1988, 112:364-370.
44. Blanas E., Carbone F.R., Allison J., Miller J.F.A.P., Heath W.R. Induction of autoimmune diabetes by oral administration of autoantigen. Science 1996, 274:1707-1709.
45. + T cells. J. Immunol. 2000, 164:2890-2896.
46. Bland P.W., Warren L.G. Antigen presentation by epithelial cells of rat small intestine. II. Selective induction of suppressor T cells. Immunology 1986, 58:9-14.
47. Bloom S., Simmons D., Jewell D.P. Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin. Exp. Immunol. 1995, 101:157-163.
48. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003, 3:253-257.
49. Bregenholt S., Wang M., Wolfe T., Hughes A., Baerentzen L., Dyrberg T., von Herrath M.G., Petersen J.S. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. Scand. J. Immunol. 2003, 57:432-438.
50. Brod S.A., Al-Sabbagh A., Sobel R.A., Hafler D.A., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens. IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann. Neurol. 1991, 29:615-622.
51. Bruce M.G., Ferguson A. The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology 1986, 59:295-300.
52. Bruce M.G., Ferguson A Oral tolerance to ovalbumin in mice: Studies of chemically modified and of "biologically filtered" antigen. Immunology 1986, 57:627-630.
53. Buer J., Lanoue A., Franzke A., Garcia C., von Boehmer H., Sarukhan H. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 1998, 187:177-183.
54. Buhlmann J.E., Foy T.M., Aruffo A., Crassi K.M., Ledbetter J.A., Green W.R., Xu J.C., Schultz L.D., Roopesian D., Flavell R.A., Fast L., Noelle R.J., Durie F.H. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995, 2:645-653.
55. Carr R.I., Etherbridge P.D., Tilley D. Failure of oral tolerance in NZB/W mice is antigen dependent and parallels antibody patterns in human systemic lupus erythematosus (SLE). Fed. Proc. 1985, 44:1542.
56. Carvalho C.R., Verdolin B.A., de Souza A.V., Vaz N.M. Indirect effects of oral tolerance in mice. Scand. J. Immunol. 1994, 39:533-538.
57. Carvalho C.R., Verdolin B.A., Vaz N.M. Indirect effects of oral tolerance cannot be ascribed to bystander suppression. Scand. J. Immunol. 1997, 45:276-281.
58. Carvalho C.R., Lenzi H.L., Correa-Oliveira R., Vaz N.M. Indirect effects of oral tolerance to ovalbumin interfere with the immune responses triggered by Schistosoma mansoni eggs. Braz. J. Med. Biol. Res. 2002, 35:1195-1199.
59. +T cell tolerance that is reversible and requires CD4-CD8-cells and interferon γ. J. Exp. Med. 1997, 186:71-81.
60. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 2000, 30:1538-1543.
61. Challacombe S.J., Thomasi T.B. Systemic tolerance and secretory immunity after oral immunisation. J. Exp. Med. 1980, 152:1459-1472.
62. Chalon M.-P., Milne R.W., Vaerman J.-P. In vitro immunosuppressive effect of serum from orally immunised mice. Eur. J. Immunol. 1979, 9:747-750.
63. Chandra R.K., Puri S., Vyas D. Malnutrition and intestinal immunity. Immunopathology of the Small Intestine 1987, 105-119. John Wiley and Sons, Chichester, UK. M.N. Marsh (Ed.).
64. Chase M.W. Inhibition of experimental drug allergy by prior feeding of the sensitivity agent. Proc. Soc. Exp. Biol. Med. 1946, 61:257-259.
65. Chen W., Jin W., Cook M., Weiner H.L., Wahl S.M. Oral delivery of group A streptococcal cell walls augments circulating TGF-β and suppresses streptococcal cell wall arthritis. J. Immunol. 1998, 161:6297-6304.
66. + T cells. J. Exp. Med. 1998, 188:1849-1857.
67. Chen W., Jin W., Tian H., Sicurello P., Frank M., Orenstein J.M., Wahl S.M. Requirement for transforming growth factor β1 in controlling T cell apoptosis. J. Exp. Med. 2001, 194:439-453.
68. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
69. Chen Y., Kuchroo V.K., Inobe J.-I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
70. Chen Y., Inobe J.-I., Marks R., Gonnella P., Kuchroo V.K., Weiner H.L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995, 376:177-180.
71. + cells mediate active suppression. J. Immunol. 1995, 155:910-916.
72. Chen Y., Inobe J.-I., Kuchroo V.K., Baron J.L., Janeway C.A., Weiner H.L. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA 1996, 93:388-391.
73. Chen Y., Inobe J.-I., Weiner H.L. Inductive events in oral tolerance in the TcR transgenic adoptive transfer model. Cell. Immunol. 1997, 178:62-68.
74. Chen Y., Song K., Eck S.L. An intra-Peyer's patch gene transfer model for studying mucosal tolerance: distinct roles of B7 and IL-12 in mucosal T cell tolerance. J. Immunol. 2000, 165:3145-3153.
75. Chen Y., Ma Y., Chen Y. Roles of CTLA-4 in the inductive phase of oral tolerance. Immunology 2002, 105:171-180.
76. Christensen H.R., Kjaer T.M., Frokiaer H. Low-dose oral tolerance due to antigen in the diet suppresses differentially the cholera toxin-adjuvantized IgE, IgA, and IgG response. Int. Arch. Allergy Immunol. 2003, 132:248-257.
77. Chung S.W., Gorczynski R.M., Dziadkowiec I., Levy G.A. Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells. Immunology 1995, 85:582-590.
78. Chung Y., Chang S.-Y., Kang C.-Y. Kinetic analysis of oral tolerance: memory lymphocytes are refractory to oral tolerance. J. Immunol. 1999, 163:3692-3698.
79. Chung Y., Choi J., Chang Y.-S., Cho S.-H., Kang C.-Y. Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology 2002, 206:408-423.
80. Chung Y., Kim D.-H., Lee S.-H., Kang C.-Y. Activation of APCs by CD40 ligation does not abrogate the induction of oral tolerance. Immunology 2004, 111:19-26.
81. Claessen A.M.E., Von Blomberg B.M.E., De Groot J., Wolvers D.A.E., Kraal G., Scheper R.J. Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization. Immunology 1996, 88:363-367.
82. Cobbold S.P., Nolan K.F., Graca L., Castejon R., Le Moine A., Frewin M., Humm S., Adams E., Thompson S., Zelenika D., Paterson A., Yates S., Fairchild P.J., Waldmann H. Regulatory T cells and dendritic cells in transplantation tolerance: Molecular markers and mechanisms. Immunol. Rev. 2003, 196:109-124.
83. Cobelens P.M., Kavelaars A., van der Zee R., van Eden W., Heijnen C.J. Dynamics of mycobacterial HSP65-induced T-cell cytokine expression during oral tolerance induction in adjuvant arthritis. Rheumatology (Oxford) 2002, 41:775-779.
84. Cobelens P.M., Kavelaars A., Vronn A., Ringeling M., van der Zee R., van Eden W., Heijnen C.J. The β2-adrenergic agonist salbutamol potentiates oral induction of tolerance suppressing adjuvant arthritis and antigen-specific immunity. J. Immunol. 2002, 169:5028-5035.
85. Collins S.R., Campbell J.B. Development of delayed hypersensitivity in gnotobiotic mice. Int. Arch. Allergy Appl. Immunol. 1980, 61:165-170.
86. Conde A.A., Stransky B., Faria A.M.C., Vaz N.M. Interruption of recently induced immune responses by oral administration of antigen. Braz. J. Med. Biol. Res. 1998, 31:377-380.
87. Cowdrey J.S., Johlin B.J. Regulation of the primary in vitro response to TNP-polymerised ovalbumin by T suppressor cells induced by ovalbumin feeding. J. Immunol. 1984, 132:2783-2789.
88. Cowdrey J.S., Curtin M.F., Steinberg A.D. Effect of prior intragastric antigen administration on primary and secondary anti-ovalbumin responses of C57Bl/6 and NZB mice. J. Exp. Med. 1982, 156:1256-1261.
89. Crabbe P.A., Heremans J.F. Selective IgA deficiency with steatorrhoea: A new syndrome. Am. J. Med. 1967, 42:319.
90. Crispe I.N., Mehal W.Z. Strange brew: T cells in the liver. Immunol. Today 1996, 17:522-525.
91. Cross A.H., Tuohy V.K., Raine C.S. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol. 1993, 146:261-270.
92. Cunningham-Rundles C. Failure of antigen exclusion. Food Allergy and Intolerance 1987, 223-226. W.B. Saunders, Eastbourne, UK. J. Brostoff, S.J. Challacombe (Eds.).
93. da Silva A.C., de Souza K.W., Machado R.C., da Silva M.F., Sant'Anna O.A. Genetics of immunological tolerance: I. Bidirectional selective breeding of mice for oral tolerance. Res. Immunol. 1998, 149:151-161.
94. da Silva M.F., da Costa S.C., Ribeiro R.C., Sant'Anna O.A., da Silva A.C. Independent genetic control of B- and T-cell tolerance in strains of mouse selected for extreme phenotypes of oral tolerance. Scand. J. Immunol. 2001, 53:148-154.
95. Dahlgren U.I.H., Wold A.E., Hanson L.A., Midtvedt T. Expression of dietary protein in E. coli renders it strongly antigenic to gut lymphoid tissue. Immunology 1991, 73:394-397.
96. Daniel D., Wegmann D.R. Protection of nonobese diabetic mice from diabetics by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA 1996, 93:956-960.
97. +CD8αα T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 2003, 100:5324-5329.
98. Dasgupta A., Kesari K.V., Ramaswamy K.K., Amenta P.S., Das K.M. Oral administration of unmodified colonic but not small intestinal antigens protects rats from hapten-induced colitis. Clin. Exp. Immunol. 2001, 125:41-47.
99. David M.F. Induction of hyporesponsiveness to particulate antigen by feeding: The sequence of immunologic response to fed antigen. J. Allergy Clin. Immunol. 1979, 64:164-170.
100. Daynes R.A., Araneo B.A., Dowell T.A., Huang K., Dudley D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Med. 1990, 171:979-996.
101. DePaolo R.W., Rollins B.J., Kuziel W., Karpus W.J. CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-β in high dose oral tolerance. J. Immunol. 2003, 171:3560-3567.
102. Deplazes P., Penhale W.J., Greene W.K., Thompson R.C. Effect on humoral tolerance (IgG and IgE) in dogs by the oral administration of ovalbumin and Der pI. Vet. Immunol. Immunopathol. 1995, 45:361-367.
103. Derry C.J., Harper N., Davies D.H., Murphy J.J., Staines N.A. Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance. Arth. Rheumat. 2001, 44:1917-1927.
104. + T cell-depleted mice. Eur. J. Immunol. 1996, 26:1756-1761.
105. + T cells. J. Immunol. 2000, 164:2515-2522.
106. deWeerd N., Bhalla P.L., Singh M.B. Oral immunization with a recombinant major grass pollen allergen induces blocking antibodies in mice. Int. Arch. Allergy Immunol. 2003, 130:119-124.
107. Dick A.D., Cheng Y.F., McKinnon A., Liversidge J., Forrester J.V. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis: A preliminary report of intranasal induction of tolerance with retinal antigens. Br. J. Ophthalmol. 1993, 77:171-175.
108. Dick A.D., Cheng Y.F., Liversidge J., Forrester J.V. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology 1994, 82:625-631.
109. Dick A.D., Sharma V., Liversidge J. Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: Implications for tolerance therapy. Br. J. Ophthalmol. 2001, 85:1001-6100.
110. Dippold W., Wittig B., Schwaeble W., Mayet W., Meyer zum Buschenfelde K.H. Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. Gut 1993, 34:1593-1597.
111. D'Orazio T.J., Niederkorn J.Y. A novel role for TGF-β and IL-10 in the induction of immune privilege. J. Immunol. 1998, 160:2089-2098.
112. D'Orazio T.J., Niederkorn J.Y. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998, 95:47-55.
113. + T cells mediating skin inflammation. Blood 2003, 102:3295-3301.
114. Duchmann R., Kaiser I., Hermann E., Mayet W., Ewe K., Meyer zum Büschenfelde K.H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 1995, 102:448-455.
115. Duchmann R., Schmitt E., Knolle P., Meyer zum Büschenfelde K.H., Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 1996, 26:934-938.
116. Eaton A.D., Xu D., Garside P. Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology 2003, 108:196-203.
117. Elson C.O., Ealding W. Generalised systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 1984, 132:2736-2741.
118. Elson C., Beagley K., Sharmanov A., Fujihashi K., Kiyono H., Tennyson G., Cong Y., Black C., Ridwan B., McGhee J. Hapten-induced model of murine inflammatory bowel disease: Mucosa immune responses and protection by tolerance. J. Immunol. 1996, 157:2174-2185.
119. Elson C., Cong Y., Iqbal N., Weaver C.T. Immuno-bacterial homeostasis in the gut: New insights into an old enigma. Semin. Immunol. 2001, 13:187-194.
120. Enders G., Gottwald T., Brendel W. Induction of oral tolerance in rats without Peyer's patches. Immunology 1986, 58:311-314.
121. Eriksson K., Holmgren J. Recent advances in mucosal vaccines and adjuvants. Curr. Opin. Immunol. 2002, 14:666-672.
122. Eriksson K., Fredriksson M., Nordstrom I., Holmgren J. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect. Immun. 2003, 71:1740-1747.
123. Ermak T., Dougherty E.P., Bhagat H.R., Kabok Z., Pappo J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells. Cell Tissue Res. 1995, 279:433-436.
124. Eynon E.E., Parker D.C. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 1992, 175:131.
125. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 1998, 101:890-898.
126. Faria A.M.C., Weiner H.L. Oral tolerance: Mechanisms and therapeutic applications. Adv. Immunol. 1999, 73:153-264.
127. Faria A.M.C., Garcia G., Rios M.J., Michalaros C.L., Vaz N.M. Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20-38-week-old mice: The effect of interval between oral exposures and rate of antigen intake in the oral immunization. Immunology 1993, 78:147-151.
128. Faria A.M.C., Ficker S.M., Speziali E., Menezes J.S., Stransky B., Rodrigues V.S., Vaz N.M. Aging affects oral tolerance induction but not its maintenance in mice. Mech. Ageing Dev. 1998, 102:67-80.
129. Faria A.M., Maron R., Ficker S.M., Slavin A.J., Spahn T., Weiner H.L. Oral tolerance induced by continuous feeding: Enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J. Autoimmun. 2003, 20:135-145.
130. Ferguson A. Models of immunologically-driven small intestinal damage. Immunopathology of the Small Intestine 1987, 225-252. John Wiley and Sons, Chichester, UK. M.N. Marsh (Ed.).
131. Fishman-Lobell J., Friedman A., Weiner H.L. Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice. Eur. J. Immunol. 1994, 24:2720-2724.
132. +T cells in the control of inflammation. J. Immunol. 2003, 171:5018-5026.
133. Fowler S., Powrie F. CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur. J. Immunol. 2002, 32:2997-3006.
134. Franco L., Benedetti R., Ferek G.A., Massouh E., Flo J. Priming or tolerization of the B and Th2 dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage. Cell Immunol. 1998, 190:1-11.
135. + T cells. J. Immunol. 2003, 171:6549-6555.
136. Friedman A., Weiner H.L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994, 91:6688-6692.
137. Fuchs E.J., Matzinger P. B cells turn off virgin but not memory T cells. Science 1992, 258:1156.
138. - T cells: γδ T cell receptor-positive T cells from nude mice abrogate oral tolerance. J. Immunol. 1989, 143:3415-3422.
139. Fujihashi K., Dohi T., Rennert P.D., Yamamoto M., Koga Y., Kiyono H., McGhee J.R. Peyer's patches are required for oral tolerance to proteins. Proc. Natl. Acad. Sci. USA 2001, 98:3310-3315.
140. Fujiwara H., Qian J.-H., Satoh S., Kokudo S., Ikegama R., Hamacka T. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by postal venous inoculation with allogeneic cells. J. Immunol. 1986, 136:2763-2768.
141. Fukaura H., Kent S.C., Pietrusewicz M.L., Khoury S.J., Weiner H.L., Hafler D.A. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 cells by oral administration of myelin in multiple sclerosis. J. Clin. Invest. 1996, 98:70-77.
142. Furrie E., Turner M.W., Strobel S. Failure of scid mice to generate an oral tolerogen after a feed of ovalbumin: A role for a functioning gut-associated lymphoid system. Immunology 1994, 83:562-567.
143. Furrie E., Turner M.W., Strobel S. Partial characterization of a circulating tolerogenic moiety which, after a feed of ovalbumin, suppresses delayed-type hypersensitivity in recipient mice. Immunology 1995, 86:480-486.
144. Furrie E., Smith R.E., Turner M.W., Strobel S., Mowat A.McI. Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of Immune Stimulating Complexes (ISCOMS). Vaccine 2002, 20:2254-2262.
145. Gaboriau-Routhiau V., Moreau M.C. Gut flora allows recovery of oral tolerance to ovalbumin in mice after transient breakdown mediated by cholera toxin or Escherichia coli heatlabile enterotoxin. Pediatr. Res. 1996, 39:625-629.
146. Galliaerde V., Desvignes C., Peyron E., Kaiserlian D. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro. Eur. J. Immunol. 1995, 25:1385-1390.
147. Garcia G., Komagata Y., Slavin A.J., Maron R., Weiner H.L. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. J. Autoimmun. 1999, 13:315-324.
148. Gardine C.A., Kouki T., DeGroot L. Characterization of the T lymphocyte subsets and lymphoid populations involved in the induction of low dose tolerance to human thyroglobulin. Cell. Immunol. 2001, 212:1-15.
149. Garg S., Bal V., Rath S., George A. Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity. Infect. Immun. 1999, 67:5917-5924.
150. Garside P., Mowat A.McI. Oral tolerance. Semin. Immunol. 2001, 13:177-185.
151. + T cells are required for the induction of oral tolerance. Int. Immunol. 1995, 7:501-504.
152. Garside P., Steel M., Worthey E.A., Satoskar A., Alexander J., Bluethmann H., Liew F.Y., Mowat A.McI. Th2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 1995, 154:5649-5655.
153. Garside P., Steel M., Worthey E.A., Kewin P.J., Howie S.E.M., Harrison D.J., Bishop D., Mowat A.McI. Oral tolerance in mice is associated with increased susceptibility of challenged lymphocytes to undergo apoptosis in vivo. Am. J. Pathol. 1996, 149:1971-1980.
154. Gautam S.C., Battisto J.R. Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J. Immunol. 1985, 135:2975-2983.
155. Gautam S.C., Chikkala N.F., Battisto J.R. Oral administration of the contact sensitizer trinitrochlorobenzene: Initial sensitization and subsequent appearance of a suppressor population. Cell Immunol. 1990, 125:437-448.
156. Glaister J.R. Some effects of oral administration of oxazolone to mice. Int. Arch. Allergy Appl. Immunol. 1973, 45:828-843.
157. Golovkina T.V., Shlomchik M., Hannum L., Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science 1999, 286:1965-1968.
158. Gonnella P.A., Chen Y., Inobe J.-I., Komagata Y., Quartulli M., Weiner H.L. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J. Immunol. 1998, 160:4708-4718.
159. Gonnella P.A., Waldner H.P., Weiner H.L. B cell deficient (μMT) mice have alterations in the cytokine microenvironment of the gut associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance. J. Immunol. 2001, 166:4456-4464.
160. + T cells. Immunology 1994, 81:27-35.
161. Gonnella P.A., Kodali D., Weiner H.L. Induction of low dose oral tolerance in monocyte chemotactic protein-1- and CCR2-deficient mice. J. Immunol. 2003, 170:2316-2322.
162. Gorczynski R.M., Hozumi N., Wolf S., Chen Z. Interleukin 12 in combination with anti-interleukin 10 reverses graft prolongation after portal venous immunization. Transplantation 1995, 60:1337-1341.
163. Gorczynski R.M., Chen Z., Hoang Y., Rossi-Bergman B. A subset of γδ T-cell receptor positive cells produce T-helper type 2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization. Immunology 1996, 87:381-389.
164. Gorczynski R.M., Cohen Z., Leung Y., Chen Z. γδ TcR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo. J. Immunol. 1996, 157:574-581.
165. Gorczynski R.M., Cohen Z., Levy G., Fu X.M. A role for γ(δ)TCR+ cells in regulation of rejection of small intestinal allografts in rats. Transplantation 1996, 62:844-851.
166. Gorczynski R.M., Chen Z., Zeng H., Fu X.M. Specificity for in vivo graft prolongation in γδ T cell receptor+ hybridomas derived from mice given portal vein donor-specific preimmunization and skin allografts. J. Immunol. 1997, 159:3698-3706.
167. Gorelik L., Flavell R.A. Abrogation of TGF β signalling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12:171-181.
168. + T cells in the normal gut mucosa. J. Immunol. 1998, 160:754-762.
169. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 2003, 100:10878-10883.
170. Greenwald R.J., Latchman Y.E., Sharpe A.H. Negative co-receptors on lymphocytes. Curr. Opin. Immunol. 2002, 14:391-396.
171. Gregerson D.S., Obritsch W.F., Donoso L.A. Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low versus high dose feeding protocols. J. Immunol. 1993, 151:5751-5761.
172. Groux H., Powrie F. Regulatory T cells in inflammatory bowel disease. Immunol. Today 1999, 20:442-446.
173. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
174. Groux H. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003, 75:8S-12S.
175. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
176. Guimaraes V.C., Quintans J., Fisfalen M.E., Straus F.H., Fields P.E., Neto G.M., DeGroot L.J. Immunosuppression of thyroditis. Endocrinology 1995, 137:2199-2207.
177. Guimaraes V.C., Quintans J., Fisfalen M.E., Straus F.H., Wilhelm K., Medeiros-Neto G.A., DeGroot L.J. Suppression of experimental autoimmune thyroiditis by oral administration of thyroglobulin. Endocrinology 1995, 136:3353-3359.
178. Gütgemann I., Fahrer A.M., Davis M.M., Chien Y.-H. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998, 8:667-673.
179. Gütgemann I., Darling J.M., Greenberg H.B., Davis M.M., Chien Y.H. A blood-borne antigen induces rapid T-B cell contact: A potential mechanism for tolerance induction. Immunology 2002, 107:420-425.
180. Hall G., Houghton C.G., Rahbek J.U., Lamb J.R., Jarman E.R. Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production. Vaccine 2003, 21:549-561.
181. Hancock W.W., Polanski M., Zhang J., Blogg N., Weiner H.L. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. Am. J. Pathol. 1995, 147:1193-1199.
182. Haneda K., Sano K., Tamura G., Sato T., Habu S., Shirato K. TGF-β induced by oral tolerance ameliorates experimental tracheal eosinophilia. J. Immunol. 1997, 159:4484-4490.
183. Hanninen A., Harrison L.C. γδ T cells as mediators of mucosal tolerance: The autoimmune diabetes model. Immunol. Rev. 2000, 173:109-119.
184. Hanninen A., Braakhuis A., Heath W.R., Harrison L.C. Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes 2001, 50:771-775.
185. Hansen G., McIntire J.J., Yeung V.P., Berry G., Thorbecke G.J., Chen L., DeKruyff R.H., Umetsu D.T. CD4(+) T helper cell sengineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 2000, 105:61-70.
186. Hanson D.G. Ontogeny of orally induced tolerance in newborns. J. Immunol. 1981, 127:1518-1522.
187. Hanson D.G., Miller S.D. Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T cells. J. Immunol. 1982, 128:2378-2381.
188. Hanson D.G., Vaz N.M., Maia L.C.S. Inhibition of specific immune responses by feeding protein Ag's. Int. Arch. Allergy Appl. Immunol. 1977, 55:526-532.
189. Hanson D.G., Vaz N.M., Maia L.C.S., Lynch J.M. Inhibition of specific immune responses by feeding protein antigens. III. Evidence against maintenance of tolerance to ovalbumin by orally induced antibodies. J. Immunol. 1979, 123:2337-2343.
190. Hanson D.G., Vaz N.M., Rawlings L.A., Lynch J.M. Inhibition of specific immune responses by feeding protein Ag's II. Effects of prior passive and active immunisation. J. Immunol. 1979, 122:2261-2266.
191. Hanson D.G., Roy M.J., Green G.M., Miller S.D. Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg. Immunol. 1993, 5:76-84.
192. Haque M.A., Mizobuchi T., Yasufuku K., Fujisawa T., Brutkiewicz R.R., Zheng Y., Woods K., Smith G.N., Cummings O.W., Heidler K.M., Blum J.S., Wilkes D.S. Evidence for immune responses to a self-antigen in lung transplantation: Role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol. 2002, 169:1542-1549.
193. Haque M.A., Yoshino S., Inada S., Nomaguchi H., Tokunaga O., Kohashi O. Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein. Eur. J. Immunol. 1996, 26:2650-2656.
194. Hara M., Kingsley C.L., Niimi M., Read S., Turvey S.E., Bushell A.R., Morris P.J., Powrie F., Wood K.J. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 2001, 166:3789-3796.
195. Harats D., Yacov N., Gilburd B., Shoenfeld Y., George J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll Cardiol. 2002, 40:1333-1338.
196. Harbige L.S., Fisher B.A. Dietary fatty acid modulation of mucosally-induced tolerogenic immune responses. Proc. Nutr. Soc. 2001, 60:449-456.
197. Harizi H., Juzan M., Pitard V., Moreau J.F., Gualde N. Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 2002, 168:2255-2263.
198. Harmatz P.R., Bloch K.J., Brown M., Walker W.A., Kleinman R.E. Intestinal adaptation during lactation in the mouse. I. Enhanced intestinal uptake of dietary protein antigen. Immunology 1989, 67:92-95.
199. Harper H., Cochrane L., Williams NA The role of small intestinal antigen-presenting cells in the induction of T-cell reactivity to soluble protein antigens: Association between aberrant presentation in the lamina propria and oral tolerance. Immunology 1996, 89:449-456.
200. Harrison L.C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited Immunol. Today 1992, 13:348-352.
201. Harrison L.C., Dempsey-Collier M., Kramer D.R., Takahashi K. Aerosol insulin induces regulatory CD8 γδT cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 1996, 184:2167-2174.
202. Hartmann B., Bellmann K., Ghiea I., Kleemann R., Kolb H. Oral insulin for diabetes prevention in NOD mice: Potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant. Diabetologia 1997, 40:902-909.
203. Hashimoto A., Yamada H., Matsuzaki G., Nomoto K. Successful priming and tolerization of T cells to orally administered antigens in B cell deficient mice. Cell. Immunol. 2001, 207:36-40.
204. + mucosal regulatory T cells are induced in gut draining lymphoid tissue within 48 hours after oral antigen application. Eur. J. Immunol. 2003, 33:2801-2810.
205. He Y.G., Mellon J., Niederkorn J.Y. The effect of oral immunization on corneal allograft survival. Transplantation 1996, 61:920-926.
206. Heppell L.M., Kilshaw P.J. Immune responses in guinea pigs to dietary protein. I. Induction of tolerance by feeding ovalbumin. Int. Archs. Allergy Appl. Immunol. 1982, 68:54-61.
207. Hershberg R.M., Mayer L.M. Antigen processing and presentation by intestinal epithelial cells-polarity and complexity. Immunol. Today 2000, 21:123-128.
208. Hershberg R.M., Cho D.H., Youakim A., Bradley M.B., Lee J.S., Framson P.E., Nepom G.T. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J. Clin. Invest. 1998, 102:792-803.
209. Higgins P.J., Weiner H. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 1988, 140:440-445.
210. Higgins S.C., Lavelle E.C., McCann C., Keogh B., McNeela E., Byrne P., O'Gorman B., Jarnicki A., McGuirk P., Mills K.H. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 2003, 171:3119-3127.
211. + T cells anergized by high dose feeding establish oral tolerance to antibody responses when transferred in SCID and nude mice. J. Immunol. 1995, 154:6238-6245.
212. Holmgren J., Czerkinsky C., Eriksson K., Mharandi A. Mucosal immunisation and adjuvants: A brief overview of recent advances and challenges. Vaccine 2003, 21(Suppl. 2):S89-S95.
213. + T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat 6 pathway. Immunity 1999, 11:463-472.
214. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
215. + T cells. Adv. Immunol. 2003, 81:331-371.
216. Hörnquist E., Lycke N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 1993, 23:2136-2143.
217. Hoyne G.F., Callow M.G., Kuhlman J., Thomas W.R. T-cell lymphokine response to orally administered proteins during priming and unresponsiveness. Immunology 1993, 78:534-540.
218. Hoyne G.F., O'Hehir R.E., Wraith D.C., Thomas W.R., Lamb J.R. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 1993, 178:1783-1788.
219. Hoyne G.F., Thomas W.R. T-cell responses to orally administered antigens: Study of the kinetics of lymphokine production after single and multiple feeding. Immunology 1995, 84:304-309.
220. Hoyne G.F., Callow M.G., Kuo M.C., Thomas W.R. Inhibition of T-cell responses by feeding peptides containing major and cryptic epitopes: studies with the Der p I allergen. Immunology 1994, 83:190-195.
221. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., MacPherson G.G. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 2000, 191:435-444.
222. Husby S., Jensenius J.C., Svehag S.-E. Passage of undergraded dietary antigen into the blood of healthy adults: Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand. J. Immunol. 1986, 24:447-452.
223. Husby S., Foged N., Host A., Svehag S.-E. Passage of dietary antigens into the blood of children with coeliac disease: Quantification and size distribution of absorbed antigens. Gut 1987, 28:1062-1072.
224. Husby S., Mestecky J., Moldoveanu Z., Holland S., Elson C.O. Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J. Immunol. 1994, 152:4663-4670.
225. Ilan Y. Immune downregulation leads to upregulation of an antiviral response: A lesson from the hepatitis B virus. Microbes Infect. 2002, 4:1317-1326.
226. Ilan Y., Prakash R., Davidson A., Jona V., Droguett G., Horwitz M., Chowdhury N.R., Chowdhury J.R. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J. Clin. Invest. 1997, 99:1098-1106.
227. Ilan Y., Sauter B., Chowdhury N.R., Reddy B.V., Thumalla N.R., Droguett G., Davidson A., Ott M., Horwitz M.S., Chowdhury J.R. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology 1998, 27:1368-1376.
228. Ilan Y., Gotsman I., Pines M., Beinart R., Zeira M., Ohana M., Rabbani E., Engelhardt D., Nagler A. Induction of oral tolerance in splenocyte recipients towards pretransplant antigens ameliorates chronic graft versus host disease in a murine model. Blood 2000, 95:3613-3619.
229. Im S.H., Barchan D., Fuchs S., Souroujon M.C. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. J. Clin. Invest. 1999, 104:1723-1730.
230. Im S.H., Barchan D., Fuchs S., Souroujon M.C. Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis. J. Neuroimmunol. 2000, 111:161-168.
231. Im S.H., Barchan D., Souroujon M.C., Fuchs S. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis. J. Immunol. 2000, 165:3599-3605.
232. Inada S., Yoshino S., Haque M.A., Ogata Y., Kohashi O. Clonal anergy is a potent mechanism of oral tolerance in the suppression of acute antigen-induced arthritis in rats by oral administration of the inducing antigen. Cell. Immunol. 1996, 175:67-75.
233. Inobe J.-I., Slavin A.J., Komagata Y., Chen Y., Liu L., Weiner H.L. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 1998, 28:2780-2790.
234. Ishii N., Moriguchi N., Sugita Y., Nakajima H., Tanaka S., Aoki I. Analysis of responsive cells in tolerance by the oral administration of ovalbumin. Immunol. Invest. 1993, 22:451-462.
235. Ishimitsu R., Yajima T., Nishimura H., Kawauchi H., Yoshikai Y. NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E. Eur. J. Immunol. 2003, 33:183-193.
236. Iwasaki A., Kelsall B.L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 1999, 190:229-239.
237. + and double negative Peyer's patch dendritic cells. J. Immunol. 2001, 166:4884-4890.
238. James M.J., Belaramani L., Prodromidou K., Datta A., Nourshargh S., Lombardi G., Dyson J., Scott D., Simpson E., Cardozo L., Warrens A., Szydlo R.M., Lechler R.I., Marelli-Berg F.M. Anergic T cells exert antigen- independent inhibition of cell:cell interactions via chemokine metabolism. Blood 2003, 102:2173-2179.
239. Jarrett E.E. Perinatal influences on IgE responses. Lancet 1984, 2:797-799.
240. Jarrett E.E., Hall E. The development of IgE-suppressive immunocompetence in young animals: Influence of exposure to antigen in the presence or absence of maternal immunity. Immunology 1984, 53:365-373.
241. Javed N.H., Gienapp I.E., Cox K.L., Whitacre C.C. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 1995, 155:1599-1605.
242. Jiang H.R., Taylor N., Duncan L., Dick A.D., Forrester J.V. Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction. Br. J. Ophthalmol. 2001, 85:739-744.
243. Jones B., Pascopella L., Falkow S. Entry of microbes into the host: using M cells to break the mucosal barrier. Curr. Opin. Immunol 1995, 7:474-478.
244. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2001, 2:301-306.
245. Ju C., Pohl L.R. Immunohistochemical detection of protein adducts of 2,4-dinitrochlorobenzene in antigen presenting cells and lymphocytes after oral administration to mice: Lack of a role of Kupffer cells in oral tolerance. Chem. Res. Toxicol. 2001, 14:1209-1217.
246. Jump R.L., Levine A.D. Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population. J. Immunol. 2002, 168:6113-6119.
247. Jung S., Gaupp S., Hartung H.P., Toyka K.V. Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat. II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN. J. Neuroimmunol. 2001, 116:21-28.
248. Kagnoff M.F. Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed type hypersensitivity reactions. J. Immunol. 1978, 120:1509-1513.
249. Kagnoff M.F. Effects of antigen-feeding on intestinal and systemic immune responses. III. Antigen-specific serum-mediated suppression of humoral antibody responses after antigen-feeding. Cell. Immunol. 1978, 40:186-203.
250. Kagnoff M.F. Effects of antigen-feeding on intestinal and systemic immune responses. IV. Similarity between the suppressor factor in mice after erythrocyte-lysate injection and erythrocyte feeding. Gastroenterology 1980, 79:54-61.
251. Kaji T., Hachimura S., Ise W., Kaminogawa S. Proteome analysis reveals caspase activation in hyporesponsive CD4 T lymphocytes induced in vivo by the oral administration of antigen. J. Biol. Chem. 2003, 278:27836-27843.
252. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 1998, 161:2804-2809.
253. Kalinski P., Hilkens C.M.U., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 1999, 20:561-567.
254. Kamphorst A.O., da Silva M.F.S., da Silva A.C., Carvalho C.R., Faria A.M.C. Selection for resistance or susceptibility to oral tolerance using OVA affects general mechanisms of tolerance induction. Ann. N.Y. Acad. Sci. 2004, 1:38.
255. Kamphorst A.O., Mendes I., Faria A.M.C., Sinisterra R. Association complexes between ovalbumin and cyclodextrins have no effect on the immunological properties of ovalbumin. Eur. J. Pharmac. Biopharmac. 2004, 57:199-205.
256. Karachunski P.I., Ostlie N.S., Okita D.K., Conti-Fine B.M. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J. Clin. Invest. 1997, 100:3027-3035.
257. Karlsson M.R., Kahu H., Hanson L.A., Telemo E., Dahlgren U.I. Neonatal colonization of rats induces immunological tolerance to bacterial antigens. Eur. J. Immunol. 1999, 29:109-218.
258. Karlsson M.R., Kahu H., Hanson L.A., Telemo E., Dahlgren U.I. Tolerance and bystander suppression, with involvement of CD25-positive cells, is induced in rats receiving serum from ovalbumin-fed donors. Immunology 2000, 100:326-333.
259. Karlsson M., Lundin S., Dahlgren U., Kahu H., Pettersson I., Telemo E. "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 2001, 31:2892-2900.
260. Karpus W.J., Lukacs N.W. The role of chemokines in oral tolerance: Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. Ann. N.Y. Acad. Sci. 1996, 778:133-144.
261. Kato H., Fujihashi K., Kato R., Yuki Y., McGhee J.R. Oral tolerance revisited: Prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses. J. Immunol. 2001, 166:3114-3121.
262. Kato H., Fujihashi K., Kato R., McGhee J.R. Lack of oral tolerance in aging is due to sequential loss of T cell responses in Peyer's patches. Int. Immunol. 2003, 15:145-158.
263. Kaufman D.I., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercaz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993, 366:69-72.
264. Kay R., Ferguson A. The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology 1989, 66:416-421.
265. Kay R., Ferguson A. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity. Immunology 1989, 66:410-415.
266. Kaya Z., Dohmen K.M., Wang Y., Schlichting J., Afanasyeva M., Leuschner F., Rose N.R. Cutting edge: A critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J. Immunol. 2002, 168:1552-1556.
267. + suppressor T cells. J. Immunol. 1996, 156:916-921.
268. Ke Y., Pearce K., Lake J.P., Ziegler H.K., Kapp J.A. γδ T lymphocytes regulate the induction of oral tolerance. J. Immunol. 1997, 158:3610-3618.
269. Kearney E.R., Pape K.A., Loh D.Y., Jenkins M.K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994, 1:327-339.
270. Kellermann S.A., McEvoy L.M. The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J. Immunol. 2001, 167:682-690.
271. Kelly K.A., Whitacre C.C. Oral tolerance in EAE: reversal of tolerance by T helper cell cytokines. J. Neuroimmunol. 1996, 66:77-84.
272. Kerlero de Rosbo N., Milo R., Lees M.B., Burger D., Bernard C.C.A., Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis: Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 1993, 92:2602-2608.
273. Khare S.D., Krco C.J., Griffiths M.M., Luthra H.S., David C.S. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J. Immunol. 1995, 155:3653-3659.
274. Khoury S.J., Lider O., Al-Sabbagh A., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol. 1990, 131:302-310.
275. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 1992, 176:1355-1364.
276. Kilshaw P.J., Cant A.J. The passage of maternal dietary proteins into human breast milk. Int. Arch. Allergy Appl. Immunol. 1984, 75:8-15.
277. Kim J.H., Ohsawa M. Oral tolerance to ovalbumin in mice as a model for detecting modulators of the immunologic tolerance to a specific antigen. Biol. Pharm. Bull. 1995, 18:854-858.
278. Kim S.-K., Reed D.S., Olson S., Schnell M.J., Rose J.K., Morton P.A., Lefrançois L. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc. Natl. Acad. Sci. USA 1998, 95:10814-10819.
279. Kim W.U., Lee W.K., Ryoo J.W., Kim S.H., Kim J., Youn J., Min S.Y., Bae E.Y., Hwang S.Y., Park S.H., Cho C.S., Park J.S., Kim H.Y. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: A novel treatment strategy for induction of oral tolerance. Arth. Rheumat. 2002, 46:1109-1120.
280. +) and B cells. J. Immunol. 1987, 139:3251-3259.
281. Kitani A., Fuss I., Nakamura K., Kumaki F., Usui T., Strober W. Transforming growth factor (TGF)-β1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β1-mediated fibrosis. J. Exp. Med. 2003, 198:1179-1188.
282. Kiyono H., McGhee J.R., Wannemuehler M.J., Michalek S.M. Lack of oral tolerance in C3H/HeJ mice. J. Exp. Med. 1982, 155:605-610.
283. Kjerrulf M., Grdic D., Ekman L., Schon K., Vajdy M., Lycke N.Y. Interferon-γ receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology 1997, 92:60-68.
284. Koga T., McGhee J.R., Kato H., Kato R., Kyono H., Fujihashi K. Evidence for early aging in the mucosal immune system. J. Immunol. 2000, 165:5352-5359.
285. Korenblatt P.E., Rothberg R.M., Minden P., Farr R.S. Immune responses of adult humans after oral and parenteral exposure to bovine serum albumin. J. Allergy 1968, 41:226-235.
286. Kraus T., Toy L., Chan L., Childs J., Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004, 126:1771-1778.
287. Krause I., Blank M., Sherer Y., Gilburd B., Kvapil F., Shoenfeld Y. Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins. Eur. J. Immunol. 2002, 32:3414-3424.
288. Kuchroo V.K., Das J.A., Brown A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995, 80:707-718.
289. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-279.
290. Kunkel D., Kirchhoff D., Nishikawa S., Radbruch A., Scheffold A. Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice. Eur. J. Immunol. 2003, 33:1292-1301.
291. Kweon M.-N., Fujihashi K., VanCott J.L., Higuchi K., Yamamoto M., McGhee J.R., Kiyono H. Lack of orally induced systemic unresponsiveness in IFN-γ knockout mice. J. Immunol. 1998, 160:1687-1693.
292. Kweon M.-N., Fujihashi K., Wakatsuki Y., Yamamoto M., McGhee J.R., Kiyono H.R. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions. J. Immunol. 1999, 162:1904-1909.
293. Lafont S., Andre C., Andre F., Gillon J., Fargier M.C. Abrogation by subsequent feeding of antibody response, including IgE in parenterally immunised mice. J. Exp. Med. 1982, 155:1573-1578.
294. Laliotou B., Dick A.D. Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens. Br. J. Ophthalmol. 1999, 83:478-485.
295. Lamont A.G., Gordon M., Ferguson A. Oral tolerance in protein-deprived mice. I. Profound antibody tolerance but impaired DTH tolerance after antigen feeding. Immunology 1987, 61:333-337.
296. Lamont A.G., Bruce M.G., Watret K.C., Ferguson A. Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology 1988, 64:135-140.
297. Lamont A.G., Mowat A.McI., Browning M.J., Parrott D.M.V. Genetic control of oral tolerance to ovalbumin in mice. Immunology 1988, 63:737-739.
298. Lamont A.G., Mowat A.McI., Parrott D.M.V. Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice. Immunology 1989, 66:595-599.
299. + T cells. J. Exp. Med. 1997, 185:405-414.
300. Lanzavecchia A. Licence to kill. Nature 1998, 393:413-414.
301. Lavelle E.C., Grant G., Pusztai A., Pfüller U., O'Hagan D.T. Mucosal immunogenicity of plant lectins in mice. Immunology 2000, 99:30-37.
302. Lavelle E.C., Grant G., Pusztai A., Pfuller U., O'Hagan D.T. The identification of plant lectins with mucosal adjuvant activity. Immunology 2001, 102:77-86.
303. Lee H.O., Miller S.D., Hurst S.D., Tan L.J., Cooper C.J., Barrett T.A. Interferon γ induction during oral tolerance reduces T-cell migration to sites of inflammation. Gastroenterology 2000, 119:129-138.
304. Lee S., Scherberg N., DeGroot L.J. Induction of oral tolerance in human autoimmune thyroid disease. Thyroid 1998, 8:229-234.
305. Lefrancois L., Altman J.D., Williams K., Olson S. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J. Immunol. 2000, 164:725-732.
306. Lefrançois L., Olson S., Masopust D. A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response. J. Exp. Med. 1999, 190:1275-1283.
307. Lehmann P., Forsthuber T., Miller A., Sercarz E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157.
308. Leishman A.J., Garside P., Mowat A.McI. Intervention in established immune responses by induction of oral tolerance. Cell Immunol. 1998, 183:137-148.
309. Leishman A.J., Garside P., Mowat A.McI. Induction of oral tolerance in the primed immune system: Influence of antigen persistence and adjuvant form. Cell Immunol. 2000, 202:71-78.
310. + T cell activation is mediated through CD8 and the activation of CD8- associated p56lck. J. Exp. Med. 1995, 182:1079-1088.
311. + T lymphocytes. J Immunol. 1989, 142:748-752.
312. Liu L.M., MacPherson G.G. Lymph-borne (veiled) dendritic cells can acquire and present intestinally administered antigens. Immunology 1991, 73:281.
313. Liu L., MacPherson G. Antigen acquisition by dendritic cells: Intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 1993, 177:1299-1307.
314. Liu L., MacPherson G.G. Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterisation. Immunology 1995, 85:88-93.
315. Liu L., Kuchroo V.K., Weiner H.L. B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance. J. Immunol. 1999, 163:2284-2290.
316. Liu Y., Janeway C.A. Interferon γ plays a critical role in induced cell death of effector T cells: A possible third mechanism of self-tolerance. J. Exp. Med. 1990, 172:1735-1739.
317. Lombardi G., Sidhu S., Batchelor R., Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994, 264:1587-1589.
318. Lombardi G., Arnold K., Uren J., Marelli-Berg F., Hargreaves R., Imami N., Weetman A., Lechler R. Antigen presentation by interferon-γ-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Eur. J. Immunol. 1997, 27:62-71.
319. Louis E., Franchimont D., Deprez M., Lamproye A., Schaaf N., Mahieu P., Belaiche J. Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice. Int. Arch. Allergy. Appl. Immunol. 1996, 109:21-26.
320. Lowney E.D. Immunologic unresponsiveness to a contact sensitizer in man. J. Invest. Dermatol. 1968, 51:411-417.
321. Lucas P.J., Kim S.-J., Melby S.J., Gress R.E. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J. Exp. Med. 2000, 191:1187-1196.
322. Lundin B.S., Dahlgren U.I., Hanson L.A., Telemo E. Oral tolerization leads to active suppression and bystander tolerance in adult rats, while anergy dominates in young rats. Scand. J. Immunol. 1996, 43:56-63.
323. Lundin B.S., Karlsson M.R., Svensson L.A., Hanson L.A., Dahlgren U.I., Telemo E. Active suppression in orally tolerized rats coincides with in situ transforming growth factor-β (TGF-β) expression in the draining lymph nodes. Clin. Exp. Immunol. 1999, 116:181-187.
324. Lycke N., Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59:301-308.
325. Lycke N., Bromander A., Ekman L., Grdic D., Hörnquist E., Kjerrulf M., Kopf M., Kosco-Vilbois M., Schon K., Vajdy M. The use of knock-out mice in studies of induction and regulation of gut mucosal immunity. Mucosal Immunol. Update 1995, 3:1-8.
326. Ma C.-G., Zhang G.-X., Xiao B.-G., Link J., Olsson T., Link H. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Neuroimmunol. 1995, 58:51-60.
327. Ma S.-W., Zhao D.-L., Mukherjee R., Singh H.B., Qin H.-Y., Stiller C.R., Jevnikar A.M. Transgenic plants expressing autoantigens fed to mice to induce oral tolerance. Nat. Med. 1997, 3:793-796.
328. MacDonald T.T. Immunosuppression caused by antigen feeding. II. Suppressor T cells mask Peyer's patch B cell priming to orally administered antigen. Eur. J. Immunol. 1983, 13:138-142.
329. MacDonald T.T., Carter P.B. Requirement for a bacterial flora before mice generate cells capable of mediating the DTH reaction to sheep red blood cells. J. Immunol. 1979, 122:2624-2629.
330. MacDonald T.T., Pender S.L.F. Lamina propria T cells. Chem. Immunol. 1998, 71:103-117.
331. MacLaren N.K., Krischer J., Crockett S., Deeb L., Marks J. Age and dose affects oral insulin tolerance therapy on endogenous insulin retention in new-onset immune-mediated (Type-1) diabetes: oral insulin therapy in Type-1 diabetes. Ann. N.Y. Acad. Sci. 2004, in press.
332. MacPherson G.G., Liu L.M. Dendritic cells and Langerhans cells in the uptake of mucosal antigens. Curr. Top. Microbiol. Immunol 1999, 236:33-53.
333. Maeda Y., Noda S., Tanaka K., Sawamura S., Aiba Y., Ishikawa H., Hasegawa H., Kawabe N., Miyasaka M., Koga Y. The failure of oral tolerance induction is functionally coupled to the absence of T cells in Peyer's patches under germfree conditions. Immunobiology 2001, 204:442-457.
334. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., Londei M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003, 362:30-37.
335. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2001, 2:816-822.
336. Maloy K.J., Donachie A.M., Ohagan D.T., Mowat A.McI. Induction of mucosal and systemic immune-responses by immunization with ovalbumin entrapped in poly(lactide-coglycolide) microparticles. Immunology 1994, 81:661-667.
337. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 2003, 197:111-119.
338. Margenthaler J.A., Landeros K., Kataoka M., Flye M.W. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction. J. Surg. Res. 2002, 104:29-35.
339. Marinaro M., Boyaka P.N., Finkelman F.D., Kiyono H., Jackson R.J., Jirillo E., McGhee J.R. Oral but not parental interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 1997, 185:415-427.
340. Maron R., Palanivel V., Weiner H.L., Harn D.A. Oral administration of schistosome egg antigens and insulin B-chain generates and enhances Th2-type responses in NOD mice. Clin. Immunol. Immunopathol. 1998, 87:85-92.
341. Maron R., Melican N.S., Weiner H.L. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. J. Autoimmun. 1999, 12:251-258.
342. Maron R., Guerau-de-Arellano M., Zhang X., Weiner H.L. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. J. Autoimmun. 2001, 16:21-28.
343. Maron R., Slavin A.J., Hoffmann E., Komagata Y., Weiner H.L. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: Cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines. Int. Immunol. 2002, 14:131-138.
344. Maron R., Sukhova G., Faria A.M., Hoffmann E., Mach F., Libby P., Weiner H.L. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002, 106:1708-1715.
345. Marth T., Strober W., Kelsall B.L. High dose oral tolerance in ovalbumin TcR-transgenic mice: systemic neutralisation of interleukin 12 augments TGFβ secretion and T cell apotosis. J. Immunol. 1996, 157:2348-2357.
346. Marth T., Zeitz M., Ludviksson B.R., Strober W., Kelsall B.L. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells. J. Immunol. 1999, 162:7233-7240.
347. Marth T., Ring S., Schulte D., Klensch N., Strober W., Kelsall B.L., Stallmach A., Zeitz M. Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice. Eur. J. Immunol. 2000, 30:3478-3486.
348. Martin E., O'Sullivan B., Low P., Thomas R. Antigenspecific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 2003, 18:155-167.
349. + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002, 100:383-390.
350. Masuda K., Horie K., Suzuki R., Yoshikawa T., Hirano K. Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens. Microbiol. Immunol. 2002, 46:55-58.
351. Matsui M., Hafler D.A., Weiner H.L. Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: Down regulation of KLH-reactive precursor-cell frequency. Ann. N.Y. Acad. Sci. 1996, 778:398-404.
352. Mattingly J.A., Waksman B.H. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J. Immunol. 1978, 121:1878-1883.
353. Mattingly J.A., Waksman B.H. Immunologic suppression after oral administration of antigen. II. Antigen specific helper and suppressor factors produced by spleen cells of rats fed sheep erythrocytes. J. Immunol. 1980, 125:1044-1047.
354. Matysiak-Budnik T., Terpend K., Alain S., Sanson le Pors M.J., Desjeux J.F., Megraud F., Heyman M. Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model. Infect Immun. 1998, 66:5785-5791.
355. Matysiak-Budnik T., Candalh C., Dugave C., Namane A., Cellier C., Cerf-Bensussan N., Heyman M. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 2003, 125:696-707.
356. Matysiak-Budnik T., van Niel G., Megraud F., Mayo K., Bevilacqua C., Gaboriau-Routhiau V., Moreau M.C., Heyman M. Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice. Infect Immun. 2003, 71:5219-5324.
357. Mayer L., Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 1987, 166:1471-1483.
358. Mayrhofer G., Pugh C.W., Barclay A.N. The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in epithelia, with special reference to the intestine. Eur. J. Immunol. 1983, 13:112-122.
359. + T cells. Immunol. Rev. 1998, 165:231-247.
360. McCarron R., Fallis R., McFarlin D. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 1990, 29:73-79.
361. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 1992, 10:75-88.
362. McHugh R.S., Shevach E.M. The role of suppressor T cells in regulation of immune responses. J Allergy Clin. Immunol. 2002, 110:693-702.
363. McKown K.M., Carbone L.D., Kaplan S.B., Aelion J.A., Lohr K.M., Cremer M.A., Bustillo J., Gonzalez M., Kaeley G., Steere E.L., Somes G.W., Myers L.K., Seyer J.M., Kang A.H., Postlethwaite A.E. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arth. Rheumat. 1999, 42:1204-1208.
364. +TcRα/β lymphocytes (putative γ/T cells). Immunology 1991, 74:234-239.
365. McMenamin C., Pimm C., McKersey M., Holt P.G. Regulation of IgE responses to inhaled antigen in mice by antigen-specific γ/δ T cells. Science 1994, 265:1869-1871.
366. McMenamin C., McKersey M., Kuhnlein P., Hunig T., Holt P.G. γ δ T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J. Immunol. 1995, 154:4390-4394.
367. Melamed D., Friedman A. Modification of the immune response by oral tolerance: Antigen requirements and interaction with immunogenic stimuli. Cell Immunol. 1993, 146:412-420.
368. Melamed D., Friedman A. In vivo tolerization of Th1 lymphocytes following a single feed with ovalbumin: Anergy in the absence of suppression. Eur. J. Immunol. 1994, 24:1974-1981.
369. Melamed D., Fischmann-Lobell J., Uni Z., Weiner H.L., Friedman A. Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int. Immunol. 1996, 8:717-724.
370. Menezes J.da S., Mucida D.de S., Cara D.C., Alvarez-Leite J.I., Russo M., Vaz N.M., Faria A.M. Stimulation by food proteins plays a critical role in the maturation of the immune system. Int. Immunol. 2003, 15:447-455.
371. Mengel J., Cardillo F., Aroeira L.S., Williams O., Russo M., Vaz N.M. Anti-γδT cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 1995, 48:97-102.
372. Metzler B., Wraith D.C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity. Int. Immunol. 1993, 5:1159-1165.
373. Meyer A.L., Benson J.M., Gienapp I.E., Cox K.L., Whitacre C.C. Suppression of murine chronic relapsing autoimmune encephalomyelitis by the oral administration of myelin basic protein. J. Immunol. 1996, 157:4230-4238.
374. Meyer A.L., Benson J., Song F., Javed N., Gienapp I.E., Goverman J., Brabb T.A., Hood L., Whitacre C.C., Iglewski B.H. Rapid depletion of peripheral antigen-specific T cells in TcR-transgenic mice after oral administration of myelin basic protein. J. Immunol. 2001, 166:5773-5782.
375. Michalek S.M., Kiyono H., Wannemuehler M.J., Mosteller L.M., McGhee J.R. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J. Immunol. 1982, 128:1992-1998.
376. Migita K., Ochi A. Induction of clonal anergy by oral administration of staphylococcal enterotoxin B. Eur. J. Immunol. 1994, 24:2081-2086.
377. Migita K., Eguchi K., Kawabe Y., Tsukada T., Ichinose Y., Nagataki S. Defective TCR-mediated signaling in anergic T cells. J. Immunol. 1995, 155:5083-5087.
378. Miller A., Lider O., Weiner H.L. Antigen-driven bystander suppression following oral administration of antigens. J. Exp. Med. 1991, 174:791-798.
379. Miller A., Lider O., Roberts A.B., Sporn M.B., Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 1992, 89:421-425.
380. Miller A., Al-Sabbagh A., Santos L.M.B., Das M.P., Weiner H.L. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 1993, 151:7307-7315.
381. Miller A., Lider O., Abramsky O., Weiner H.L. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur. J. Immunol. 1994, 24:1026-1032.
382. Miller B.G., Newby T.J., Stokes C.R., Bourne F.J. Influence of diet on postweaning malabsorption and diarrhoea in the pig. Res. Vet. Sci. 1984, 36:187-193.
383. Miller B.G., Whittemore C.T., Stokes C.R., Telemo E. The effects of delayed weaning on the development of oral tolerance to soya-bean protein in pigs. Br. J. Nutr. 1994, 71:615-625.
384. Miller C.C., Cook M.E. Evidence against the induction of immunological tolerance by feeding antigens to chickens. Poultry Sci. 1994, 73:106-112.
385. Miller J.E.A.P., Heath W.R. Self-ignorance in the peripheral T-cell pool. Immunol. Rev. 1993, 133:131-150.
386. Miller M.L., Cowdrey J.S., Curtin M.F. Gastrointestinal tolerance in autoimmune mice. Fed. Proc. 1983, 42:942.
387. Miller S.D., Hanson D.G. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J. Immunol. 1979, 123:2344-2350.
388. Min W.P., Zhou D., Ichim T.E., Strejan G.H., Xia X., Yang J., Huang X., Garcia B., White D., Dutartre P., Jevnikar A.M., Zhong R. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J. Immunol. 2003, 170:1304-1312.
389. Monfardini C., Milani M., Ostlie N., Wang W., Karachunski P.I., Okita D.K., Lindstrom J., Conti-Fine B.M. Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes. J. Neuroimmunol. 2002, 123:123-134.
390. Monsonego A., Beserman Z.P., Kipnis J., Yoles E., Weiner H.L., Schwartz M. Beneficial effect of orally administered myelin basic protein in EAE-susceptible Lewis rats in a model of acute CNS degeneration. J. Autoimmun. 2003, 21:131-138.
391. Monteleone G., Pender S.L., Wathen N.C., MacDonald T.T. Interferon-α drives T cell-mediated immunopathology in the intestine. Eur. J. Immunol. 2001, 31:2247-2255.
392. Monteleone G., Pender S.L.F., Alstead E., Hauer A.C., Lionetti P., MacDonald T.T. Role of interferon α in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 2001, 48:425-429.
393. Moreau M.C., Corthier G. Effect of the gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice. Infect. Immunol. 1988, 56:2766-2768.
394. Moreau M., Gaboriau-Routhiau V. The absence of gut flora, the doses of antigen ingested and ageing affect the longterm peripheral tolerance induced by ovalbumin feeding in mice. Res. Immunol. 1996, 147:49-59.
395. + T cells. J. Exp. Med. 1993, 178:237-244.
396. + regulatory T cells. J. Immunol. 2003, 170:3939-3943.
397. Mowat A.McI. The immunopathogenesis of food sensitive enteropathies. Local Immune Responses of the Gut 1984, 199-225. CRC Press, Boca Raton, FL. T.J. Newby, C.R. Stokes (Eds.).
398. Mowat A.McI. The role of antigen recognition and suppressor cells in mice with oral tolerance to ovalbumin. Immunology 1985, 56:253-260.
399. Mowat A.McI. Depletion of suppressor T cells by 2′-deoxyguanosine abrogates tolerance in mice fed ovalbumin and permits the induction of intestinal delayed-type-hypersensitivity. Immunology 1986, 58:179-184.
400. Mowat A.McI. The regulation of immune responses to dietary protein antigens. Immunol. Today 1987, 8:93-95.
401. Mowat A.McI. Intestinal graft-versus-host disease. Graft Versus Host Disease 1997, 337-384. Marcel Dekker, New York. J.M. Ferrara, J.H. Deeg, S.J. Burakoff (Eds.).
402. Mowat A.McI. Induction of peripheral tolerance by portal vein administration of antigen. The Immunology of the Liver 1999, 101-115. John Wiley & Sons, New York. I.N. Crispe (Ed.).
403. Mowat A.McI. Oral tolerance; physiology, and clinical implications. Curr. Opin. Gastroenterol. 1999, 15:546-556.
404. Mowat A.McI., Ferguson A. Hypersensitivity in the small intestinal mucosa. V. Induction of cell mediated immunity to a dietary antigen. Clin. Exp. Immunol. 1981, 43:574-582.
405. Mowat A.McI., Ferguson A. Migration inhibition of lymph node lymphocytes as an assay for regional cell-mediated immunity in the intestinal lymphoid tissues of mice immunised orally with ovalbumin. Immunology 1982, 47:365-370.
406. Mowat A.McI.I., Parrott D.M.V. Immunological responses to fed protein antigens in mice. IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology 1983, 50:547-554.
407. Mowat A.McI., Strobel S., Drummond H.E., Ferguson A. Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 1982, 45:104-113.
408. Mowat A.McI., Thomas M.J., Mackenzie S., Parrott D.M.V. Divergent effect of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice. Immunology 1986, 58:677-684.
409. Mowat A.McI., Lamont A.G., Bruce M.G. A genetically determined lack of oral tolerance to ovalbumin is due to failure of the immune system to respond to intestinally derived tolerogen. Eur. J. Immunol. 1987, 17:1673-1676.
410. Mowat A.McI., Maloy K.J., Donachie A.M. Immune stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens. Immunology 1993, 80:527-534.
411. Mowat A.McI., Steel M., Leishman A.J., Garside P. Normal induction of oral tolerance in the absence of a functional IL12 dependent γ interferon signalling pathway. J. Immunol. 1999, 163:4728-4736.
412. Mucida D.S., Rodrigues D., Keller A.C., Gomes E., Faria A.M.C., Russo M. Decreased nasal tolerance to allergic asthma in mice fed an amino acid-based protein-free diet. Ann. N.Y. Acad. Sci. 2004, in press.
413. Mueller D.L., Jenkins M.K. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol 1995, 7:375-381.
414. Mueller D.L., Jenkins M.K., Schwartz R.H. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Ann. Rev. Immunol. 1989, 7:445-480.
415. Myers L.K., Higgins G.C., Finkel T.H., Reed A.M., Thompson J.W., Walton R.C., Hendrickson J., Kerr N.C., Pandya-Lipman R.K., Shlopov B.V., Stastny P., Postlethwaite A.E., Kang A.H. Juvenile arthritis and autoimmunity to type II collagen. Arth. Rheumat. 2001, 44:1775-1781.
416. Nagata S., McKenzie C., Pender S.L.F., Bajaj-Elliott M., Fairclough P.D., Walker-Smith J., Monteleone G., MacDonald T.T. Human Peyer's patch T cells are sensitised to dietary antigens and display a T helper cell type 1 cytokine profile. J. Immunol. 2000, 165:5315-5321.
417. + regulatory T cells in Peyer's patch. Ann. N.Y. Acad. Sci. USA 2004, in press.
418. Nagler-Anderson C., Bober L.A., Robinson M.E., Siskind G.W.A., Thorbecke G.J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II antigen. Proc. Natl. Acad. Sci. USA 1986, 83:7443-7446.
419. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 2001, 194:629-644.
420. + regulatory T cell activity in both humans and mice. J. Immunol. 2004, 172:834-842.
421. Nakao A., Kasai M., Kumano K., Nakajima H., Kurasawa K., Iwamoto I. High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways. Int. Immunol. 1998, 104:387-394.
422. Nelson P.A., Akeslband Y., Dearborn S., Al-Sabbagh A., Tian Z.J., Gonnella P., Zamvil S., Chen Y., Weiner H.L. Effect of oral β interferon on subsequent immune responsiveness. Ann. N.Y. Acad. Sci. 1996, 778:145-155.
423. Neurath M.F., Fuss I., Kelsall B.L., Presky D.H., Waegell W., Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 1996, 183:2605-2616.
424. Newberry R.D., Stenson W.P., Lorenz R.G. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat. Med. 1999, 5:900-906.
425. Newberry R.D., McDonough J.S., Stenson W.F., Lorenz R.G. Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestinal lamina propria: Directing the tone of the intestinal immune response. J. Immunol. 2001, 166:4465-4472.
426. Newby T.J., Stokes C.R., Bourne F.J. Effects of feeding bacterial lipopolysaccharide and dextran sulphate on the development of oral tolerance to contact sensitizing agents. Immunology 1980, 41:617-621.
427. Ngan J., Kind L.S. Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J. Immunol. 1978, 120:861-865.
428. Niederkorn J.Y. Immunology and immunomodulation of corneal transplantation. Int. Rev. Immunol. 2002, 21:173-196.
429. Niederkorn J.Y., Mayhew E. Phenotypic analysis of oral tolerance to alloantigens: evidence that the indirect pathway of antigen presentation is involved. Transplantation 2002, 73:1493-1500.
430. Niimi M., Takashina M., Ikeda Y., Shirasugi N., Shatari T., Takami H., Kodaira S., Kameyama K., Matsumoto K., Hamano K., Esato K. Mice treated with anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase. Transplant. Proc. 2000, 32:2086.
431. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., Sollid L.M., Jahnsen J., Scott H., Brandtzaeg P. Gluten induces an intestinal cytokine response strongly dominated by interferon γ in patients with celiac disease. Gastroenterology 1998, 115:551-563.
432. Nishimura M., Fujiyama Y., Niwakawa M., Sasaki T., Bamba T. In vivo cytokine responses in gut-associated lymphoid tissue (GALT) and spleen following oral administration of staphylococcal enterotoxin B. Immunol. Lett. 2002, 81:77-85.
433. Nussenblatt R.B., Caspi R.R., Mahdi R., Chan C.-C., Roberge F., Lider O., Weiner H.L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 1990, 144:1689-1696.
434. Nussenblatt R.B., Gery I., Weiner H.L., Ferris F., Shiloach J., Ramaley N., Perry C., Caspi R., Hafler D.A., Foster S., Whitcup S.M. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am. J. Ophthal. 1997, 123:583-592.
435. Oh J.W., Seroogy C.M., Meyer E.H., Akbari O., Berry G., Fathman C.G., Dekruyff R.H., Umetsu D.T. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced air-way hyperreactivity and inflammation. J. Allergy Clin. Immunol. 2002, 110:460-468.
436. +CD45RBhigh-induced colitis by a TGF-β-dependent mechanism. J. Immunol. 2003, 170:2516-2522.
437. Okumura S., McIntosh K., Drachman D.B. Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis. Ann. Neurol. 1994, 36:704-713.
438. Oliveira F.M., Santos E.M., Mota-Santos T.A., Ruiz-De- Souza V., Gontijo C.M. Covalent coupling of palmitate to ovalbumin inhibits and blocks the induction of oral tolerance. Scand. J. Immunol. 2002, 55:570-576.
439. O'Mahony S., Arranz E., Barton J.R., Ferguson A. Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut 1991, 32:29-35.
440. Owen R.L. M cells: entryways of opportunity for enteropathogens. J. Exp. Med. 1994, 180:7-9.
441. Pape K.A., Kearney E.R., Khoruts A., Mondino A., Merica R., Chen Z.-M., Ingulli E., White J., Johnson J.G., Jenkins M.K. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cells for the study of T-cell activation in vivo. Immunol. Rev. 1997, 156:67-78.
442. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell 1994, 76:241-251.
443. Pecquet S., Pfeifer A., Gauldie S., Fritsché R. Immunoglobulin E suppression and cytokine modulation in mice orally tolerized to β-lactoglobulin. Immunology 1999, 96:278-285.
444. Pecquet S., Leo E., Fritsche R., Pfeifer A., Couvreur P., Fattal E. Oral tolerance elicited in mice by β-lactoglobulin entrapped in biodegradable microspheres. Vaccine 2000, 18:1196-1202.
445. Peng H.-J., Turner M.W., Strobel S. The kinetics of oral hyposensitisation to a protein antigen are determined by immune status and the timing, dose, and frequency of antigen administration. Immunology 1989, 67:425-430.
446. Peng H.-J., Turner M.W., Strobel S. Failure to induce oral tolerance to protein antigens in neonatal mice can be corrected by transfer of adult spleen cells. Pediatr. Res. 1989, 26:486-490.
447. Peng H.-J., Turner M.W., Strobel S. The generation of a "tolerogen" after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin. Exp. Immunol. 1990, 81:510-515.
448. Peng H.-J., Chang Z.-N., Han S.-H., Won M.-H., Huang B.-T. Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH responses in mice. Scand. J. Immunol. 1995, 42:297-304.
449. Peng H.-J., Chang Z.-N., Lee C.-C., Kuo S.-W. B-cell depletion fails to abrogate the induction of oral tolerance of specific Th1 immune responses in mice. Scand. J. Immunol. 2000, 51:454-460.
450. Perez V.L., Parijs L.V., Biuckians A., Zheng X.X., Strom T.B., Abbas A.K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997, 6:411-417.
451. Perez-Machado M.A., Ashwood P., Thomson M.A., Latcham F., Sim R., Walker-Smith J.A., Murch S.H. Reduced transforming growth factor-β1-producing T cells in the duodenal mucosa of children with food allergy. Eur. J. Immunol. 2003, 33:2307-2315.
452. Peri B.A., Rothberg R.M. Circulating antitoxin in rabbits after ingestion of diphtheria toxin. Infect. Immunity 1981, 32:1148-1154.
453. Petersen J.S., Bregenholt S., Apostolopolous V., Homann D., Wolfe T., Hughes A., De Jongh K., Wang M., Dyrberg T., Von Herrath M.G. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Clin. Exp. Immunol. 2003, 134:38-45.
454. Peterson K.E., Braley-Mullen H. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell Immunol. 1995, 166:123-130.
455. Phipps P.A., Stanford M.R., Sun J.B., Xiao B.G., Holmgren J., Shinnick T., Hasan A., Mizushima Y., Lehner T. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur. J. Immunol. 2003, 33:224-232.
456. + regulatory T-cells. Diabetes 1999, 48:2150-2156.
457. Popat S., Hearle N., Hogberg L., Braegger C.P., O'Donoghue D., Falth-Magnusson K., Holmes G.K., Howdle P.D., Jenkins H., Johnston S., Kennedy N.P., Kumar P.J., Logan R.F., Marsh M.N., Mulder C.J., Torinsson Naluai A., Sjoberg K., Stenhammar L., Walters J.R., Jewell D.P., Houlston R.S. Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. Ann. Hum. Genet. 2002, 66:125-137.
458. Pope C., Kim S.K., Marzo A., Masopust D., Williams K., Jiang J., Shen H., Lefrancois L. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J. Immunol. 2001, 166:3402-3409.
459. Poussier P., Ning T., Banerjee D., Julius M. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J. Exp. Med. 2002, 195:1491-1497.
460. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995, 3:171-174.
461. + T cells. J. Exp. Med. 1996, 183:2669-2674.
462. Prakken B.J., van der Zee R., Anderton S.M., van Kooten P.J., Kuis W., van Eden W. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc. Natl. Acad. Sci. USA 1997, 94:3284-3289.
463. Prakken B.J., Roord S., van Kooten P.J., Wagenaar J.P., van Eden W., Albani S., Wauben M.H. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arch. Rheumat. 2002, 46:1937-1946.
464. Premier R.R., Meeusen E.N.T. Lymphocyte surface marker and cytokine expression in peripheral and mucosal lymph nodes. Immunology 1998, 94:363-367.
465. Qian J.-H., Hashimoto T., Fujiwara H., Hamaoka T. Studies on the induction of tolerance to alloantigens. 1. The abrogation of potentials for delayed-type hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells. J. Immunol. 1985, 134:3656-3661.
466. Quinn A., Melo M., Ethell D., Sercarz E.E. Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-A(g7)-expressing mouse strains. Int. Immunol. 2001, 13:1321-1333.
467. Rask C., Holmgren J., Fredriksson M., Lindblad M., Nordström I., Sun J.-B., Czerkinsky C. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Clin Exp Allergy 2000, 30:1024-1032.
468. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000, 192:295-302.
469. Reynolds J., Pusey C.D. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J. Am. Soc. Nephrol. 2001, 12:61-70.
470. Richman L.K., Chiller J.M., Brown W.R., Hanson D.G., Vaz N.M. Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J. Immunol. 1978, 121:2429-2434.
471. Richman L.K., Graeff A.S., Yarchoan R., Strober W. Simultaneous induction of antigen-specific IgA helper T cells and IgA suppressor T cells in the murine Peyer's patch after protein feeding. J. Immunol. 1981, 126:2079-2083.
472. Richman L.K., Graeff A.S., Strober W Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch. Cell Immunol. 1981, 62:110-118.
473. Rizzo L.V., Miller-Rivero N.E., Chan C.-C., Wiggert B., Nussenblatt R.B., Caspi R.R. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest. 1994, 94:1668-1672.
474. Rizzo L.V., Morawetz R.A., Miller-Rivero N.E., Choi R., Wiggert B., Chan C.-C., Morse H.C., Nusenblatt R.B., Caspi R.R. IL-4 and IL-10 are both required for the induction of oral tolerance. J. Immunol. 1999, 162:2613-2622.
475. Roberts S.J., Smith A.L., West A.B., Wen L., Findly R.C., Owen M.J., Hayday A.C. T-cell α β+ and γ δ+ deficient mice
476. Roelofs-Haarhuis K., Wu X., Nowak M., Fang M., Artik S., Gleichmann E. Infectious nickel tolerance: A reciprocal interplay of tolerogenic APCs and T suppressor cells that is driven by immunization. J. Immunol. 2003, 171:2863-2872.
477. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunol. Rev. 2001, 182:68-79.
478. Rubin D., Weiner H.L., Fields B.N., Greene M.I. Immunologic tolerance after oral administration of reovirus: Requirement for two viral gene products for tolerance induction. J. Immunol. 1981, 127:1697-1701.
479. Russo M., Jancar S., Pereira de Siqueira A.L., Mengel J., Gomes E., Ficker S.M., Caetano de Faria A.M. Prevention of lung eosinophilic inflammation by oral tolerance. Immunol. Lett. 1998, 61:15-23.
480. Russo M., Nahori M.A., Lefort J., Gomes E., de Castro Keller A., Rodriguez D., Ribeiro O.G., Adriouch S., Gallois V., de Faria A.M., Vargaftig B.B. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am. J. Respir. Cell Mol. Biol. 2001, 24:518-526.
481. + T cell anergy in vitro. J. Exp. Med. 1998, 187:89-96.
482. Sadeghi H., Bregenholt S., Wegmann D., Petersen J.S., Holmgren J., Lebens M. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Immunology 2002, 106:237-245.
483. + regulatory T cells that express toll-like receptors. J. Exp. Med. 2003, 197:397-401.
484. Saklayen M.G., Pesce A.J., Pollak V.E., Michael J.G. Induction of oral tolerance in mice unresponsive to bacterial lipopolysaccharide. Infect. Immun. 1983, 41:1383-1385.
485. Saklayen M.G., Pesce A.J., Pollak V.E., Michael J.G. Kinetics of oral tolerance: Study of variables affecting tolerance induced by oral administration of antigen. Int. Arch. Allergy Appl. Immunol. 1984, 73:75-79.
486. Samoilova E.B., Horton J.L., Zhang H., Khoury S.J., Weiner H.L., Chen Y. CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 1998, 10:491-498.
487. Sanderson I., Ouellette AJ, Carter EA, Walker WA, Harmatz PR Differential regulation of B7 mRNA in enterocytes and lymphoid cells. Immunology 1993, 79:434-438.
488. Santos L.M.B., Al-Sabbagh A., Londono A.A., Weiner H.L. Oral tolerance to myelin basic protein induces regulatory TGR-β secreting cells in Peyer's patches of SJL mice. Cell Immunol 1994, 157:439-447.
489. Sato M.N., Oliveira C.R., Futata E.A., Victor J.R., Maciel M., Fusaro A.E., Carvalho A.F., Duarte A.J. Oral tolerance induction to Dermatophagoides pteronyssinus and Blomia tropicalis in sensitized mice: occurrence of natural autoantibodies to immunoglobulin E. Clin. Exp. Allergy 2002, 32:1667-1674.
490. Sato S., Qian J.-H., Kokudo S., Ikegami R., Suda T., Hamaoka T., Fujiwara H. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route. J. Immunol 1988, 140:717-722.
491. Sayegh M.H., Khoury S.J., Hancock W.H., Weiner H.L., Carpenter C.B. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc. Natl. Acad. Sci. USA 1992, 89:7762-7766.
492. Sayegh M.H., Zhang Z.J., Hancock W.W., Kwok C.A., Carpenter C.B., Weiner H.L. Down-regulation of the immune response to histocompatibility antigen and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation 1992, 53:163-166.
493. Schoenberger S.P., Toes R.E.M., van der Voort E.I.H., Offringa R., Melief C.J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393:480-483.
494. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 2003, 21:305-334.
495. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2002, 2:116-226.
496. Sher A., Pearce E., Kaye P. Shaping the immune response to parasites: Role of dendritic cells. Curr. Opin. Immunol. 2003, 15:421-429.
497. Shi F.D., Li H., Wang H., Bai X., van der Meide P.H., Link H., Ljunggren H.G. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells. J. Immunol. 1999, 162:5757-5763.
498. Shi H.N., Grusby M.J., Nagler-Anderson C. Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J. Immunol. 1999, 162:5143-5148.
499. Shi H.N., Liu H.Y., Nagler-Anderson C. Enteric infection as an adjuvant for the response to a model food antigen. J. Immunol. 2000, 165:6174-6182.
500. Sieper J., Kary S., Sörensen H., Alten R., Eggens U., Hüge W., Hiepe F., Kühne A., Listing J., Ulbrich N., Braun J., Zink A., Mitchison N.A. Oral type II collagen treatment in early rheumatoid arthritis: A double blind, placebo-controlled, randomized trial. Arth. Rheumat. 1996, 39:41-51.
501. Silverman G.A., Peri B.A., Rothberg R.M. Systemic antibody responses of different species following ingestion of soluble protein antigens. Dev. Comp. Immunol. 1982, 6:737-746.
502. Singh V.K., Kalra H.K., Yamaki K., Shinohara T. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Cell Immunol. 1992, 139:81-90.
503. Singh V.K., Anand R., Sharma K., Agarwal S. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen. Cell. Immunol. 1996, 172:158-162.
504. Skyler J.S. The effects of oral insulin in relatives of patients with type 1 diabetes. Ann. N.Y. Acad. Sci. 2004, in press.
505. Slavin A.J., Maron R., Weiner H.L. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int. Immunol. 2001, 13:825-833.
506. Sloan-Lancaster J., Allen P.M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Ann. Rev. Immunol. 1996, 14:1-27.
507. Smith K.M., Davidson J.M., Garside P. T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology 2002, 106:144-158.
508. Smith K.M., McAskill F., Garside P. Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help. J. Immunol. 2002, 168:4318-4325.
509. Sollid L.M. Coeliac disease: Dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2002, 2:647-655.
510. Sonoda K.H., Exley M., Snapper S., Balk S.P., Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune privileged site. J. Exp. Med. 1999, 190:1215-1226.
511. Soos J.M., Stuve O., Youssef S., Bravo M., Johnson H.M., Weiner H.L., Zamvil S.S. Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J. Immunol. 2002, 169:2231-2235.
512. Spahn T.W., Issazadah S., Salvin A.J., Weiner H.L. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR δ chain gene. Eur. J. Immunol. 1999, 29:4060-4071.
513. Spahn T.W., Fontana A., Faria A.M., Slavin A.J., Eugster H.P., Zhang X., Koni P.A., Ruddle N.H., Flavell R.A., Rennert P.D., Weiner H.L. Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur. J. Immunol. 2001, 31:1278-1287.
514. Spahn T.W., Weiner H.L., Rennert P.D., Lugering N., Fontana A., Domschke W., Kucharzik T. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur. J. Immunol. 2002, 32:1109-1113.
515. Staines N.A., Harper N., Ward F.J., Malmström V., Holmdahl R., Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 1996, 103:368-375.
516. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.
517. Steptoe R.J., Thomson A.W. Dendritic cells and tolerance induction. Clin. Exp. Immunol. 1996, 105:397-402.
518. Stokes C.R. Induction and control of intestinal immune responses. Local Immune Responses of the Gut 1984, 97-141. CRC Press, Boca Raton, FL. C.R. Stokes, T.J. Newby (Eds.).
519. Stokes C.R., Newby T.J., Huntley J.H., Patel D., Bourne F.J. The immune response of mice to bacterial antigens given by mouth. Immunology 1979, 38:497-502.
520. Stokes C.R., Newby T.J., Bourne F.J. The influence of oral immunization on local and systemic immune responses to heterologous antigens. Clin. Exp. Immunol. 1983, 52:399-406.
521. Stokes C.R., Swarbrick E.T., Soothill J.F. Genetic differences in immune exclusion and partial tolerance to ingested antigens. Clin. Exp. Immunol. 1983, 52:678-684.
522. Stokes C.R., Miller B.G., Bourne F.J. Animal models of food sensitivity. Food Allergy and Intolerance 1987, 286-300. W. B. Saunders, Eastbourne, UK. J. Brostoff, S.J. Challacombe (Eds.).
523. Streilein J.W. Immunologic privilege of the eye. Springer Semin. Immunopathol. 1999, 21:95-111.
524. Strobel S., Ferguson A. Modulation of intestinal and systemic immune responses to a fed protein. Gut 1986, 27:829-837.
525. Strobel S., Ferguson A. Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell mediated immune responses. Immunology 1987, 60:317-318.
526. Strobel S., Mowat A.McI. Immune responses to dietary antigens: Oral tolerance. Immunol. Today 1998, 19:173-181.
527. Strobel S., Mowat A.McI., Drummond H.E., Pickering M.G., Ferguson A. Immunological responses to fed protein antigens in mice. 2. Oral tolerance for CMI is due to activation of cyclophosphamide sensitive cells by gut processed antigen. Immunology 1983, 49:451-456.
528. Strobel S., Ferguson A. Immune responses to fed protein antigens in mice. III. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr. Res. 1984, 18:588-594.
529. Strobel C., Mowat A.McI., Ferguson A. Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice. Immunology 1985, 56:57-64.
530. Strober W., Fuss I.J., Blumberg R.S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 2002, 20:495-549.
531. Strober W., Kelsall B., Fuss I., Marth T., Ludviksson B., Ehrhardt R., Neurath M. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol. Today 1997, 18:61-64.
532. Stumbles P.A., Thomas J.A., Pimm C.L., Lee P.T., Venaille T.J., Proksch S., Holt P.G. Resting respiratory tract dendritic cells preferentially stimulate helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J. Exp. Med. 1998, 188:2019-2031.
533. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 1997, 159:1739-1745.
534. Sugihara R., Matsumoto Y., Ohmori H. Suppression of IgE antibody response in mice by a polysaccharide, AZ9, produced by Klebsiella oxytoca strain TNM3. Immunopharmacol. Immunotoxicol. 2002, 24:245-254.
535. Suko M., Mori A., Ito K., Okudaira H. Oral immunotherapy may induce T cell anergy. Int. Arch. Allergy Immunol. 1995, 107:278-281.
536. + T cell tolerance to soluble antigens. Immunol. Lett. 2002, 84:125-132.
537. Sun J., Dirden-Kramer B., Ito K., Ernst P.B., Van Houten N. Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 1999, 162:5865-5875.
538. Sun J., Stalls M.A., Thompson K.L., Fisher Van Houten N. Cell cycle block in anergic T cells during tolerance induction. Cell Immunol. 2003, 225:33-41.
539. Sun J.-B., Holmgren J., Czerkinsky C. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 1994, 91:10795-10799.
540. Sun J.-B., Rask C., Olsson T., Holmgren J., Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 1996, 93:7196-7201.
541. Sun J.-B., Xiao B.-G., Lindblad M., Li B.-L., Link H., Czerkinsky C., Holmgren J. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against acute and chronic experimental autoimmune encephalomyelitis by inducing TGF-β secreting cells and suppressing chemokine expression. Int. Immunol. 2000, in press.
542. Suzuki I., Kitamura K., Kiyono H., Kurita T., Green D.R., McGhee J.R. Isotype-specific immunoregulation: Evidence for a distinct subset of T contrasuppressor T cells for IgA responses in murine Peyer's patches. J. Exp. Med. 1986, 164:501-516.
543. Suzuki I., Kiyono H., Kitamura K., Green D.R., McGhee J.R. Abrogation of oral tolerance by contrasuppressor T cells suggests the presence of regulatory networks in the mucosal immune system. Nature 1986, 320:451-454.
544. Swarbrick E.T., Stokes C.R., Soothill J.F. Absorption of antigens after oral immunization and the simultaneous induction of specific systemic tolerance. Gut 1979, 20:121-125.
545. Taams L.S., van Rensen A.J.M.L., Poelen M.C.M., van Els C.A.C.M., Besseling A.C., Wagenaar J.P.A., van Eden W., Wauben M.H.M. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur. J. Immunol. 1998, 28:2902-2912.
546. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 1998, 10:1969-1980.
547. Takeda H., Spatz M., Ruetzler C., McCarron R., Becker K., Hallenbeck J. Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats. Stroke 2002, 33:2156-2163.
548. Takeuchi M., Alard P., Streilein J.W. TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 1998, 160:1589-1597.
549. +T cell function during in vivo memory or tolerance induction. Immunity 1998, 8:581-590.
550. Teitelbaum D., Arnon R., Sela M. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc. Natl. Acad. Sci. USA 1999, 96:3842-3847.
551. Terato K., Xiu J.Y., Miyahara H., Cremer M.A., Griffiths M.M. Induction of chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide. Br. J. Rheumatol. 1996, 35:1-11.
552. + T cells by dendritic cell-derived exosomes. Nat. Immunol. 2002, 3:1156-1162.
553. Thomas H.C., Ryan C.J., Benjamin I.S., Blumgart L.H., MacSween R.N.M. The immune system response in cirrhotic rats: The induction of tolerance to orally administered protein antigens. Gastroenterology 1976, 71:114-117.
554. Thompson H.S., Staines N.A. Could specific oral tolerance be a therapy for autoimmune disease?. Immunol. Today 1990, 11:396-399.
555. Thompson H.S.G., Staines N.A. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin. Exp. Immunol. 1986, 64:581-586.
556. Thompson H.S.G., Harper N., Bevan D.J., Staines N.A. Suppression of collagen induced arthritis by oral administration of type II collagen: Changes in immune and arthritic responses mediated by active peripheral suppression. Autoimmunity 1993, 16:189-199.
557. Thompson S.J., Thompson H.S.G., Harper N., Day M.J., Coad A.J., Elson C.J., Staines N.A. Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology 1993, 79:152-157.
558. Thomson A.W., O'Connell P.J., Steptoe R.J., Lu L. Immunobiology of liver dendritic cells. Immunol. Cell Biol. 2002, 80:65-73.
559. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998, 188:287-296.
560. + immunoregulatory T cells is antigen non-specific. J. Immunol. 2000, 164:183-190.
561. + T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 2001, 167:188-195.
562. Thurau S.R., Chan C.-C., Nusenblatt R.B., Caspi R.R. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): Induction of protective tolerance in primed animals. Clin. Exp. Immunol. 1996, 109:370-376.
563. Thurau S.R., Diedrichs-Mohring M., Fricke H., Burchardi C., Wildner G. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis. Immunol. Lett. 1999, 68:205-212.
564. Tian J., Atkinson M.A., Clare-Salzler M., Herschenfeld A., Forsthuber T., Lehmann P.V., Kaufman D.L. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 1996, 183:1561-1567.
565. Tisch R., Yang X.-D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993, 366:72-75.
566. Titus R.G., Chiller J.M. Orally-induced tolerance: Definition at the cellular level. Int. Arch. Allergy Appl. Immunol. 1981, 65:323-338.
567. Tobagus I.T., Thomas W.R., Holt P.G. Adjuvant costimulation during secondary antigen challenge directs qualitative aspects of oral tolerance induction, particularly during the neonatal period. J. Immunol. 2004, 172:2274-2285.
568. Tomasi T.B., Barr W.G., Challacombe S.J., Curran G. Oral tolerance and accessory cell function of Peyer's patches. Ann. N.Y. Acad. Sci. 1983, 409:145-163.
569. Trentham D.E., Dynesius-Trentham R.A., Orav E.J., Combitchi D., Lorenzo C., Sewell K.L., Hafler D.A., Weiner H.L. Effects of oral administration of collagen on rheumatoid arthritis. Science 1993, 261:1727-1730.
570. Troncone R., Ferguson A. In mice, gluten in maternal diet primes systemic immune responses to gliadin in offspring. Immunology 1988, 64:533-537.
571. Trop S., Samsonov D., Gotsman I., Alper R., Diment J., Ilan Y. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology 1999, 29:746-755.
572. Tsuji N.M., Mizumachi K., Kurisaki J. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 2001, 103:458-464.
573. Tsuji N.M., Mizumachi K., Kurisaki J. Antigen-specific, CD4(+)CD25(+) regulatory T cell clones induced in Peyer's patches. Int. Immunol. 2003, 15:525-534.
574. + regulatory T cells in Peyer's patches. Ann. N.Y. Acad. Sci. 2004, in press.
575. Turcanu V., Maleki S.J., Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J. Clin. Invest. 2003, 111:1065-1072.
576. Unger W.W.J., Hauet-Broere F., Jansen W., van Berkel L.A., Kraal G., Samsom J.N. Early events in peripheral regulatory T cell induction via the nasal mucosa. J. Immunol. 2003, 171:4592-4603.
577. Untersmayr E., Scholl I., Swoboda I., Beil W.J., Forster-Waldl E., Walter F., Riemer A., Kraml G., Kinaciyan T., Spitzauer S., Boltz-Nitulescu G., Scheiner O., Jensen-Jarolim E. Antacid medication inhibits digestion of dietary proteins and causes food allergy: A fish allergy model in BALB/c mice. J. Allergy Clin. Immunol. 2003, 112:616-623.
578. Van der Heijden P.J., Bianchi A.T.J., Dol M., Pals J.W., Stok W., Bokhout B.A. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice. Immunology 1991, 72:89-93.
579. van Hage-Hamsten M., Johansson E., Roquet A., Peterson C., Andersson M., Greiff L., Vrtala S., Valenta R., Gronneberg R. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis. Clin. Exp. Allergy 2002, 32:1448-1453.
580. Van Hoogstraten I.M., Boos C., Boden D., Von Blumberg M.E., Scheper R.J., Kraal G. Oral induction of tolerance to nickel sensitization in mice. J. Invest. Dermatol. 1993, 101:26-31.
581. Van Houten N., Blake S.F. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 1996, 157:1337-1341.
582. van Niel G., Raposo G., Candalh C., Boussac M., Hershberg R., Cerf-Bensussan N., Heyman M. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001, 121:337-349.
583. Van Niel G., Mallego I.J., Bevilacqua C., Candalh C., Brugiere S., Tomaskovic-Crook E., Heath J.K., Cerf-Bensussan N., Heyman M. Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. Gut 2003, 52:1690-1697.
584. Vaz N.M., Maia L.C.S., Hanson D.G., Lynch J.M. Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen. J. Allergy Clin. Immunol. 1977, 60:110-115.
585. Vendetti S., Chai J.G., Dyson J., Simpson E., Lombardi G., Lechler R. Anergic T cells inhibit the antigen-presenting function of dendritic cells. J. Immunol. 2000, 165:1175-1178.
586. Vezys V., Lefrancois L. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J. Immunol. 2002, 169:6677-6680.
587. Vezys V., Olson S., Lefrancois L. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity 2000, 12:505-514.
588. Viney J.L., Mowat A.McI., O'Malley J.M., Williamson E., Fanger N. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 1998, 160:5815-5825.
589. Vistica B.P., Chanaud N.P., Felix N., Caspi R.R., Rizzo I.V., Nussenblatt R.B., Gery I. CD8 T-cells are not essential for the induction of "low dose" oral tolerance. Clin. Immunol. Immunopathol. 1996, 78:196-202.
590. Vives J., Parks D.E., Weigle W.O. Immunologic unresponsiveness after gastric administration of human γ-globulin: antigen requirements and cellular parameters. J. Immunol. 1980, 125:1811.
591. von Herrath M.G., Dyrberg T., Oldstone M.B.A. Oral insulin treatment suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest. 1996, 98:1324-1331.
592. Vrabec T.R., Gregerson D.S., Dua H.S., Donoso L.A. Inhibition of experimental autoimmune uveoretinitis by oral administration of s-antigen and synthetic peptides. Autoimmunity 1992, 12:175-184.
593. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605-617.
594. Waldo F.B., Van Den Wall Bake A.W.L., Mestecky J., Husby S. Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 1994, 72:30-34.
595. Walker W.A. Role of the mucosal barrier in antigen handling by the gut. Food Allergy and Intolerance 1987, 209-222. W. B. Saunders, Eastbourne, UK. J. Brostoff, S.J. Challacombe (Eds.).
596. Wang Z.Y., Qiao J., Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J. Neuroimmunol. 1993, 44:209-214.
597. Wang Z.Y., Qiao J., Melms A., Link H. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell Immunol. 1993, 152:394-404.
598. Wang Z.Y., Link H., Ljungdahl A., Hojeberg B., Link J., He B., Qiao J., Melms A., Olsson T. Induction of interferon-γ, interleukin-4, and transforming growth factor-β in rats orally tolerized against autoimmune myaesthenia gravis. Cell Immunol. 1994, 157:353-368.
599. Wang Z.Y., He B., Qiao J., Link H. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: Double tolerance. J. Neuroimmunol. 1995, 63:79-86.
600. Wannemuehler M.J., Kiyono H., Babb J.L., Michalek S.M., McGhee J.R. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J. Immunol. 1982, 129:959-965.
601. + T cells expressing CD95 ligand and secreting IL-4 in the liver. J. Immunol. 2002, 168:2188-2199.
602. + cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology 2003, 38:403-412.
603. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 1997, 18:335-343.
604. Weiner H.L., Komagata Y. Oral tolerance and the treatment of rheumatoid arthritis. Springer Semin. Immunopathol. 1998, 20:289-308.
605. Weiner H.L., Mackin G.A., Matsui M., Orav E.J., Khoury S.J., Dawson D.M., Hafler D.A. Double-blind pilot trial of tolerization with myelin antigens in multiple sclerosis. Science 1993, 259:1321-1324.
606. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trentham D.E., Hafler D.A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. 1994, 12:809-838.
607. Weiner H.L., Lemere C.A., Maron R., Spooner E.T., Grenfell T.J., Mori C., Issazadeh S., Hancock W.W., Selkoe D.J. Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 2000, 48:567-579.
608. Wells H.G., Osborne T.B. The biological reactions of the vegetable proteins. I. Anaphylaxis. J. Infect. Dis. 1911, 8:66-124.
609. Whitacre C.C., Gienapp I.E., Orosz C.G., Bitar D.M. Oral tolerance in experimental autoimmune encephalitis. III. Evidence for clonal anergy. J. Immunol. 1991, 147:2155-2163.
610. Whitacre C.C., Gienapp I.E., Meyer A., Cox K.L., Javed N. Oral tolerance in experimental autoimmune encephalomyelitis. Ann. N.Y. Acad. Sci. 1996, 778:217-227.
611. Whitacre C.C., Song F., Wardrop R., Campbell K., McLain M., Benson J., Gienapp I.E. Regulation of autoreactive T cell function by oral tolerance to self antigens. Ann. N.Y. Acad. Sci. 2004, in press.
612. Wildner G., Thurau S.R. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Eur. J. Immunol. 1995, 25:1292-1297.
613. Wildner G., Hünig T., Thurau S.R. Orally induced, peptide-specific γδ TcR+ cells suppress experimental autoimmune uveitis. Eur. J. Immunol. 1996, 26:2140-2148.
614. Williamson E., O'Malley J.M., Viney J.L. Defining the role of dendritic cells in oral tolerance induction by visualizing the T cell response elicited by oral administration of soluble protein antigen. Immunology 1999, 97:565-572.
615. Williamson E., Westrich G.M., Viney J.L. Modulating dendritic cells to optimize mucosal immunization protocols. J. Immunol. 1999, 163:3668-3675.
616. Williamson E., Bilsborough J.M., Viney J.L. Regulation of mucosal dendritic cell function by receptor activator of NF-κ B (RANK)/RANK ligand interactions: Impact on tolerance induction. J. Immunol. 2002, 169:3606-3612.
617. Wilson A.D., Stokes C.R., Bourne F.J. Adjuvant effect of cholera toxin on the mucosal immune response to soluble proteins: Differences between mouse strains and protein antigens. Scand. J. Immunol. 1989, 29:739-745.
618. Wilson A.D., Bailey M., Williams N.A., Stokes C.R. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur. J. Immunol. 1991, 21:2333-2339.
619. Wolvers D.A.W., van der Cammen M.J.F., Kraal G. Mucosal tolerance is associated with, but independent of, upregulation of Th2 responses. Immunology 1997, 92:328-333.
620. Wolvers D.A.W., Coenen-De Roo C.J.J., Mebius R.E., Van Der Cammen M.J.F., Tirion F., Miltenburg A.M.M., Kraal G. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: Studies with OVA and human cartilage gp39. J. Immunol. 1999, 162:1994-1998.
621. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., Choi Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997, 186:2075-2080.
622. Wrenshall L.E., Ansite J.D., Eckman P.M., Heilman M.J., Stevens R.B., Sutherland D.E. Modulation of immune responses after portal venous injection of antigen. Transplantation 2001, 71:841-850.
623. Wu H.Y., Ward F.J., Staines N.A. Histone peptide-induced nasal tolerance: Suppression of murine lupus. J. Immunol. 2002, 169:1126-1134.
624. Wu X.-M., Nakashima M., Watanabe T. Selective suppression of antigen-specific Th2 cells by continuous micro-dose oral tolerance. Eur. J. Immunol. 1998, 28:134-142.
625. Xiao B.G., Zhang G.X., Shi F.D., Ma C.G., Link H. Decrease of LFA-1 is associated with upregulation of TGF-β in CD4(+) T cell clones derived from rats nasally tolerized against experimental autoimmune myasthenia gravis. Clin. Immunol. Immunopathol. 1998, 89:196-204.
626. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 2003, 170:394-399.
627. Yang R., Liu Q., Grosfeld J.L., Pescovitz M.D. Intestinal drainage through liver is a pre-requisite for oral tolerance induction. J. Paediatr. Surg 1994, 29:1145-1148.
628. Yasufuku K., Heidler K.M., O'Donnell P.W., Smith G.N., Cummings O.W., Foresman B.H., Fujisawa T., Wilkes D.S. Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am. J. Respir. Cell Mol. Biol. 2001, 25:26-34.
629. Yoshida H., Hachimura S., Hirahara K., Hisatsune T., Shiraishi A., Kaminogawa S. Induction of oral tolerance in splenocyte-reconstituted SCID mice. Clin. Immunol. Immunopathol 1998, 87:282-291.
630. Yoshino S. Treatment with anti-IL4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen. J. Immunol. 1998, 160:3067-3071.
631. Yoshino S., Yoshino J. Effect of a monoclonal antibody against interleukin-4 on suppression of antigen-induced arthritis in mice by oral administration of the inducing antigen. Cell Immunol. 1998, 187:139-144.
632. Yoshino S., Quattrocchi E., Weiner H.L. Oral administration of type II collagen suppresses antigen-induced arthritis in Lewis rats. Arth. Rheumat. 1995, 38:1092-1096.
633. Yoshitomi T., Hirahara K., Kawaguchi J., Serizawa N., Taniguchi Y., Saito S., Sakaguchi M., Inouye S., Shiraishi A. Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide. Immunology 2002, 107:517-522.
634. Zemann B., Schwaerzler C., Griot-Wenk M., Nefzger M., Mayer P., Schneider H., de Weck A., Carballido J.M., Liehl E. Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-β expression and prevents allergy in adult life. J Allergy Clin. Immunol. 2003, 111:1069-1075.
635. Zhang J., Lee C.S.Y., Lider O., Weiner H.L. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 1990, 145:2489-2493.
636. Zhang J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 1991, 88:10252-10256.
637. Zhang J., Markovic S., Raus J., Lacet B., Weiner H.L., Hafler D.A. Increased frequency of IL-2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 1993, 179:973-984.
638. + regulatory T cells by oral antigen administration. J. Immunol. 2001, 167:4245-4253.
639. Zhang Z., Michael J.G. Orally inducible immune unresponsiveness is abrogated by IFNγ treatment. J. Immunol. 1990, 144:4163-4165.
640. + regulatory cells. J. Immunol. 2001, 167:107-113.
641. Zimmer K.P., Buning J., Weber P., Kaiserlian D., Strobel S. Modulation of antigen trafficking to MHC class II-positive late endosomes of enterocytes. Gastroenterology 2000, 118:128-137.
642. Zivny J.H., Moldoveanu Z., Vu H.L., Russell M.W., Mestecky J., Elson C.O. Mechanisms of immune tolerance to food antigens in humans. Clin. Immunol 2001, 101:158-168.
643. Zou L.P., Ma D.H., Levi M., Wahren B., Wei L., Mix E., van der Meide P.H., Link H., Zhu J. Antigen-specific immunosuppression: Nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats. J. Neuroimmunol. 1999, 94:109-121.